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Molecular imaging is a technique that can be used to visualize complex biochemical 
processes without perturbing living organisms, and it has been playing increasingly important 
roles for the early detection of disease states and monitoring the results of therapies. Among 
molecular imaging techniques, Positron Emission Tomography (PET) has significant advantages 
compared with other techniques, which includes its high sensitivity and high spatial resolution, 
and most importantly, its ability to provide functional information, whereas MRI or CT provide 
largely anatomical information. Among commonly used positron-emitting radionuclides, fluorine-
18 has a number of preferred characteristics which are, 1) longest half-life, 109 minutes, 2) lowest 
maximum energy and 3) purest mode of decay. However, F-18 radiolabeling method is still 
underdeveloped, and thus, practical radiosyntheses are limited to nucleophilic substitution, 
especially at alkyl positions. Therefore, to extend the utility of F-18 for PET radiotracers, novel 
radiolabeling methods with F-18 that enable the preparation of a wide variety of radiotracers, 
rapidly, efficiently and conveniently are in highly demand in the field of radiochemistry.  
Chapter 1 presents an introduction of PET imaging techniques, and outlines the basics of 
F-18 radiochemistry, which focuses on the synthetic difficulties associated with the nature of 
fluoride and especially F-18. It also highlights the current efforts placed on the development of 
novel fluorination methods toward F-18 radiosynthesis, especially C-F bond formation on 
electron-rich aromatic rings and use of fluorophilic elements for rapid preparation of radiotracers.  
Chapter 2 discusses the development of a facile a fluorination method that produces ortho-
fluorophenols from non-aromatic precursors. We have found that α-diazocyclohexenones 
undergo halofluorination with fluoride ion as fluoride source, and the following hydrohalide 
elimination and tautomerization afford ortho-fluorophenols rapidly.  The translation to F-18 
radiolabeling was achieved using organic soluble phase transfer catalysis under carrier-added 
conditions. Although labeling under non-carrier-added conditions is still a work in progress, our 
current progress points to a new approach to label electron-rich aromatic rings rapidly and at high 
specific activity (SA).  
Chapter 3 discusses the development of a kit-like radiosynthetic method using a resin-
supported silicon based precursor. We have found that silyl esters have significant advantages 
over previously reported methods; they undergo F-18 incorporation under very mild conditions, 
with F-18 water straight from the cyclotron used without any drying. We further developed the 
resin-supported method which enables simple purification of the radiotracer. The utility of this 
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I. Molecular Imaging Background 
A. Background 
Molecular imaging is a technique that can be used for imaging living organisms without 
perturbing them, and developments of non-invasive imaging techniques are playing increasingly 
important roles in diagnosis and in monitoring the results of therapy. In particular, these imaging 
methods assist medical diagnosis as measurement tools for disease states through in vivo 
visualization of the presence and function of biomolecules.1 In the past, biological and medical 
imaging was done by methods, such as magnetic resonance imaging (MRI), X-ray computed 
tomography (CT) or ultrasound, that reveal mostly anatomical states. Molecular imaging, by 
contrast, has developed to meet the demand for functional imaging, to understand presence and 
function of disease-related biomolecules by using target specific biomarkers (tracers), which can 
be tracked from outside the body of experimental animals or humans without perturbing them.2 
Although similar information can be obtained from tumor biopsies and subsequent 
histopathological evaluations, this approach is associated with difficulties and risks (especially for 
the brain!). Furthermore, heterogeneity,3,4 sampling errors,5 and variations in the expression 
profiles of targets between primary and metastatic sites6,7 complicate the biopsy-dependent 
approach and thus may not provide detailed biochemical information at the earliest stage of 
disease, which is at a point when symptoms have progressed only minimally and cures from the 
application of appropriate therapies are more likely to be successful. Advances in molecular 
imaging, however, can enable early detection of disease, refine staging and prognosis, and 
predict the success of therapeutic regimens that are customized to be most appropriate for the 
status of an individual patient. These advantages clearly highlight the potential of molecular-based 
imaging techniques to improve the efficacy and clinical outcome from targeted therapies with the 
additional potential impacts of reducing medical cost, safeguard against the use of unnecessary 
harmful medical procedures, and improve the quality of life.  
B. Nuclear Medicine and Molecular Imaging Modalities 
Nuclear medicine is based on the use of radioactive materials for diagnosis and therapy 
of disease. The high penetration ability of the signals of the radiotracers used in nuclear medicine 
enable the detection of their distribution from outside of the body of the patient with high sensitivity. 
An optimally designed radiotracer binds to a specific target molecule associated with disease and 
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provides in detail information on the location and population of the target to assist in understanding 
the stage of the disease. Unlike traditional imaging techniques, such as MRI and CT that provide 
anatomical images associated with structural abnormalities related to pathologies, molecular 
imaging techniques, such as PET (Positron Emission Tomography) and SPECT (Single Photon 
Emission Computed Tomography), because of their high sensitivity, offer more detailed 
information based on molecular biochemistry, thereby providing images that are functional rather 
than anatomical.  
A comparison of imaging modalities widely used today is shown in Table 1.1. The primary 
advantage of nuclear imaging approaches is its high sensitivity, so that the mass of radiotracer 
administered to patients is so low that the toxicity of the imaging agents is generally not an issue. 
Moreover, PET imaging, particularly, has several advantages, compared to SPECT, of being fully 
quantitative and providing higher special resolutions. However, one of the disadvantages of 
nuclear imaging methods is their lower spatial resolution compared with that of CT or MRI. To 
overcome this problem, fusion of molecular information of PET or SPECT with high resolution 
anatomical information from CT or MRI is playing an important role in routine clinical molecular 
imaging protocols.  
 





























0.2-0.1 50-3000 103-106 10-3-10-5 >300 
PET Annihilation 
photons 
3-8 1-300 1-100 10-11-10-12 >300 
SPECT -photons 5-12 60-2000 1-1000 10-10-10-11 >300 
 
II. Positron Emission Tomography 
A. Background 
Positron emission tomography (PET) imaging is a powerful non-invasive imaging 
technique which utilizes positron-emitting radiotracers to obtain “functional” images, whereas 
3 
 
other imaging modalities, such as magnetic resonance imaging (MRI) and computed tomography 
(CT), provide “anatomical” images. PET has significant advantages associated with the high 
sensitivity to detection of positron decays and its ability to measure metabolic processes in living 
patients. PET imaging provides important physiological and biochemical information quantitatively 
regarding the onset and progression of diseased states by monitoring the uptake and 
biodistribution of a positron-emitting radiotracer in the patient’s body over a given period of time.9 
 
Figure 1.1. 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) 
The impact of PET as medical and research tool is significant.10 [18F]fluorodeoxyglucose 
(1, Figure 1.1) is the most extensively used and most widely studied PET tracer, and it is used in 
approximately 90% of all PET scans worldwide.11 FDG/PET takes advantage of the high uptake 
and metabolic processing of glucose in tumors (the Warburg effect), and FDG behaves similarly 
to glucose because it is a structural mimic of glucose, with the C-2 hydroxy group being replaced 
by fluorine. FDG enters the cell with assistance from glucose transporter proteins and undergoes 
phosphorylation at the C-6 hydroxyl as does normal glucose, but due to its lack of a 2-hydroxyl 
group, it does not undergo further glycolysis process, and thus remains trapped inside of the cell.12 
The accumulation of the phosphorylated radiotracer in tumor cell results high image contrast with 
normal tissue.13 FDG is commonly used as a tracer in oncology, including the detection of breast, 
lung, and colorectal cancers.14 PET has also provided useful information for the early detection 
of neurodegenerative disorders, such as Alzheimer’s15,16 and Parkinson’s diseases.17,18 The 
advantage of PET in this area is due to its ability to access brain tissue, which is conventionally 
done by risky brain autopsies, and thus greatly facilitates diagnoses in living patients. PET has 
also been extensively utilized in cardiology as a myocardial imaging tool to characterize coronary 
heart disease.19  
B. The Principle of PET 
The probes for PET imaging are labeled with positron-emitting radionuclides, nuclides 
which are proton rich and undergo decay process by the emission of a positively charged particle, 
the positron, an antimatter particle corresponding to an electron, having an identical mass but 




Scheme 1.1. The decay process for positron-emitting radionuclides. 
 
Proton-rich nuclei hold excess positive charge and tends to reach more stable energy 
states by two different decay process, positron emission and electron capture, and the lower 
atomic weight nuclei (e.g., 18F, 11C) tend to undergo positron emission, whereas the higher atomic 
weight ones (e.g., 123I) tend to undergo electron capture. When a radionuclide undergoes positron 
emission decay, the emitted positron is not detected directly, but it first travels a short distance 
(typically 0.5-2.0 mm depending on radionuclide and the kinetic energy of the positron particle 
itself), during which time it interacts with the surrounding medium and decelerates to an energy 
minimum; at this point it interacts with an electron. This collision results in an annihilation event 
between an antimatter particle, the proton, and a matter particle, the electron, converting the mass 
of both of them into pure energy.  Thus, annihilation of the two particles yield two photons of 511 
keV energy each, which is in the gamma ray energy range, and these photons are emitted at the 
same time and at approximately 180o to each other (Figure 1.2), i.e., simultaneous and transaxial. 
It is the simultaneous detection of the two emitted annihilation photons that enables the origin of 
the annihilation event to be localized along the line of coincidence, and from multiple coincidence 
detections, a three-dimensional image can be reconstructed, using similar back projection 
mathematical analyses used to construct a three-dimensional CT image. The resulting image 
provides details of the accumulation of the PET radiotracer within a given tissue, the resolution 
being limited both to the physical design of the PET camera and the average distance traveled 
by the positron before its annihilation, the radionuclides producing low energy positrons giving the 




Figure 1.2. Schematic representation of a positron decay and an annihilation event that result in 
a PET image. A. A positron and an electron annihilate producing simultaneously two 511 keV 
photons travelling in opposite directions along a common axis. B. The 511 keV photons are 
registered by a circular array of gamma ray detectors that constitute the PET camera.20  
III. Radiotracers for PET 
A. Available Positron Emitters for PET 
Positron-emitting, proton-excess isotopes of the main elements found in biomolecules 
(e.g., C, N and O) are often used to prepare radiotracers for PET imaging. This is a desirable 
feature for PET since radiosynthesis using these labeled probes can often be chemically identical 
to their non-radioactive counterpart and thus, they can function without any change of the in vivo 
biological behavior of the original compounds that might occur if structural analogs were used. 
Although fluorine is not found most natural molecules, the replacement of a hydrogen atom or a 
hydroxyl group with fluorine is a widely applied bioisosteric replacement. Due to its ability to form 
stable bonds with carbon and its small size, these substitutions with fluorine generally do not 
interfere with binding. In fact, in drug development, fluorine is often introduced deliberately with 
the intention of increasing drug binding affinity for their molecular targets by changing the 
electronic character of the molecule or of obtaining better in vivo pharmacokinetic behavior and 
thereby increased potency by simply blocking possible sites of metabolic oxidation.21  
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Table 1.2. Nuclear properties of commonly used positron-emitting radionuclides. 
Radionuclide Half-life (min) 
Maximum Energy 
(MeV) 
Mode of Decay 
11C 20 0.97 + (99%) 
13N 10 1.20 + (100%) 
15O 2 1.74 + (100%) 
18F 109 0.64 
+ (97%) 
EC (3%) 
82Rb 1.27 3.15 + (95%) 
 
Among the most common positron-emitting radionuclides, fluorine-18 has a number of 
preferred characteristics which are, 1) longest half-life, 109 minutes, 2) lowest maximum energy 
and 3) purest mode of decay. Radiotracer synthesis has to be accomplished rapidly because of 
the short half-lives of these radionuclides, and the longer half-life of fluorine-18 offers chemists 
enough time for work-up, purification and further transformation if needed. As mentioned before, 
the kinetic energy of the emitted positron is directly related to the resolution of the PET image, 
because the higher the energy, the greater distance traveled by the positron before annihilation 
occurs, and it is the site of positron-electron annihilation that is detected by the PET camera, not 
the position of the radionuclide undergoing the decay. The distance traveled by a positron emitted 
from fluorine-18 is, therefore, shortest among those radionuclides and thus, fluorine-18 is often 
considered the isotope of choice for PET imaging.   
B. Synthetic Aspect of Short-lived Radioisotope 
There are several aspects that one has to consider for radiotracer syntheses with short-
lived radioisotopes. First, the labeled probe preparation has to be accomplished within, at most, 
two or three half-lives of the radioisotope. To match this requirement, the whole synthetic route to 
the radiotracer must be designed with the radioisotope incorporation step as late as possible, 
ideally as the last step. This also generally requires mild conditions for the radiolabeling step so 
that functional groups already present in the precursors can be tolerated; the incorporation of the 
radioisotope into the substrate should be efficient as well as rapid. All post radiolabeling 
procedures should also be simple and efficient, and these include, potentially, additional chemical 
steps (often deprotections) as well as work-up, purification, product identity verification, and 
further transformation and formulation needed for injection to patients. Second, since typically a 
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large excess of precursor and reagents are used (103-104 fold higher than the concentration of 
the isotope) to achieve efficient incorporation with trace levels of radioisotope, an efficient work-
up/purification procedure has to be established, with the notable characteristic being a clean 
separation of the labeled material both from other radiolabeled byproducts but also any unlabeled 
material, whether identical to or different from the desired radiolabeled product. Another problem 
associated with developing effective radiosynthetic protocols is the difficulty in testing reaction 
conditions in cold laboratory settings that can be reproduced in the hot laboratory. Lastly, to 
handle hazardous radioisotopes, the laboratory set-up needs to be designed to protect 
researchers from exposure to possible radioactivity contamination. To shield the radiation, the 
working area in the fume hood needs to be surrounded by lead bricks and a thick lead-glass 
window, which is typically the arrangement found in commercial hot cells, and all of the 
procedures need to be performed using tools, such as tweezers to maximize the distance 
between the radioactivity and the researchers. These restrictions required for radiosafety are 
necessary but they can even make a simple operation difficult.  
C. Radiochemical Yields 
Radiochemical yields (RCYs), which express the ratio of radioactivity incorporation to 
radioactivity used in the reaction, is one of the important parameters in radiochemistry. RCYs can 
be reported in two ways: decay-corrected and non-decay-corrected yields. Decay corrected yields, 
which are calculated from the end of bombardment of the target, indicate the overall efficiency of 
the radiochemical reactions and purifications to give usable product, irrespective of the elapsed 
time required for synthesis and purification, and they are most often cited in the development of 
new methodology. Non-decay-corrected yields, determined from the total amount of radiotracer 
activity after all synthetic and purification steps are completed, provide a more practical and 
informative account of overall efficiency of the complete preparation procedure and purification. 
D. Specific Activity and Effective Specific Activity 
Specific activity, often abbreviated as SA, is another important parameter in 
radiochemistry. It is defined as the amount of radioactivity per mass of compound that includes 
both radiolabeled and non-radiolabeled. SA is typically reported in Ci/mmol or GBq/μmol, and 
high SA means that the contamination of the non-labeled version of the compound in the 
radiotracer preparation is minimal. This is critical, especially when targeting physiologically low 
concentration receptors, such as nuclear receptors. With these targets the number of available 
binding sites for radiotracers is limited; so, the accumulation of sufficient levels of activity for 
imaging requires high specific activity radiotracers. The uptake of radioactivity with radiotracers 
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of low specific activity (i.e., those that contain significant amount of non-labeled compound) is 
limited due to saturation of the binding sites with non-labeled compound. As a result, image 
intensity is low and acquisition times are long; signal-to-noise ratios and image contrast can also 
suffer. Furthermore, with low specific activity tracers, the total mass of injected material may be 
high enough to cause pharmacological and toxic side effects. Typically, SA values of 1000 
Ci/mmol or greater are considered high enough for PET imaging of low abundance targets.  
There are several factors that contribute to the SA values of labeled compounds. First, 
these values are directly dependent on the half-life of radionuclides, which means that the shorter 
the half-life is, the higher is the theoretical maximum SA value. For instance, theoretical SA of 
fluorine-18 (half-life: 109 minutes) is 1710 Ci/μmol, whereas that of carbon-11 (half-life: 20 
minutes) is 9220 Ci/μmol. Second, nonradioactive nuclides can be found in substrates, reagents 
and solvents, such as fluorine-19 that can dilute the specific activity of fluorine-18, or carbon-12 
absorbed from atmospheric carbon dioxide that can dilute the specific activity of carbon-11. 
Furthermore, it is known that some materials used in set-ups for radionuclide production, e.g., 
even Teflon HPLC lines and seals when exposed to high levels of radioactivity, can leak stable 
isotopes that cause significant reduction of SAs.22,23 Lastly, large excess of materials used in 
radiotracer synthesis can complicate purification, requiring significant effort to fully isolate the 
desired radioactive compound from unlabeled compound, including unreacted precursor and 
byproducts. This becomes a serious problem when a high SA radiotracer is contaminated with 
unlabeled compounds that are chemically different from the radiotracer yet still are capable of 
binding to the target site for imaging. In this case, strictly speaking, the SA of the radiotracer is 
not lowered principle, but is lowered in terms of its potential for imaging; this situation is referred 
to as low effective specific activity (ESA). 
IV. Chemistry of [18F]Fluoride Ion 
A. Background 
Among those radionuclides available for PET, fluorine-18 is a widely used radioisotope 
due to its favorable characteristics, as discussed above. Despite those positive properties, 
however, the application of radiochemistry of F-18 has not reached an ideal status as yet. 
Especially its incorporation to the more complex molecules such as peptides and proteins is far 
from being convenient, and there are only limited methods available for researchers to prepare 
radiotracers labeled with F-18. In general, there are many fluorination methods using F-19 cold 
chemistry; these can be divided into two classes; nucleophilic fluorination and electrophilic 
fluorination. As a matter of fact, in many cases, the direct transfer of interesting fluorination 
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reactions, known from literature, from applications in F-19 chemistry to F-18 radiochemistry often 
fails due to the fact that the behavior of minute amounts of F-18 that are required for the 
preparation of high SA radiotracers is different from that of macroscopic amounts of F-19. 
Furthermore, although there are many fluorinating reagents and fluoride source that can be used 
in F-19 cold chemistry, the F-18 versions of these are frequently limited because currently 
available production methods for F-18 limit the chemical forms in which it can be obtained.  
B. [18F]Fluoride Production 
The non-radioactive fluorine-19 is the most stable isotope of fluorine, and it has a natural 
abundance of 100%. Fluorine-18, on the other hand, has one less neutron, making it proton rich, 
and unstable or radioactive, and giving it a half-life of 109 minutes. It undergoes decay processes 
to stabilize the nuclei by emitting positron (97%) (Figure 1.4.) or, more rarely, by capturing an 
electron (3%). The most convenient way to produce such an unstable isotope like F-18 is to 
bombard a stable isotope (i.e., an isotope with a proton/neutron ratio of 0.8 – 1.0), with protons 
or deuterons, thus generating a proton-rich nucleus. The most widely used production method of 
F-18 is a bombardment of O-18 with a high energy proton. Collision of the proton with the O-18 
nucleus causes emission of a neutron, which results [18F]fluoride, the nuclear reaction being 
designated as 18O(p,n)18F. For F-18 production, it is best to use highly enriched O-18 (typically 
>95%) because when O-16 is also bombarded by protons, it produces a different radioactive 
nuclide, nitrogen-13 (16O(p,α)13N).  
 
Scheme 1.2. The decay process for the positron-emitting radionuclide 18F. 
Typical liquid targets for bombardment consist of a solid target body containing the target 
fluid and a thin foil that encloses the target material yet allows penetration of the beam. Due to 
the high energy of the bombarding particles, the materials used to fabricate the target body and 
foil need to be very strong, able to withstand high pressures as the target fluid is heated by the 
bombarding particles, be chemically inert under gas plasma conditions, and have a good thermal 
conductivity. For fabricating the target body, normally aluminium, titanium, nickel, niobium, 
tantalum or silver are used, and the typical material for the target foil is Havar alloy, which consists 
of multiple metals including cobalt, chromium, nickel and others. In fact, trace amounts of these 
metal ions are ejected into the target water as the proton beam passes through the foil to enter to 
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target and bombard the water. Thus, unless purified, the [18F]fluoride produced in such a target is 
contaminated by trace levels of these metals.  
C. Electrophilic Fluorination with [18F]F2 
Significant efforts were made to develop production for [18F]F2 due to the demand for 
electrophilic fluorination agents. There are two major methods to produce [18F]F2: starting from a 
neon-20 gas target (20Ne(d,α)18F) or an oxygen-18 gas target (by the same nuclear reaction as 
above). Within the gas target, where the F-18 is produced by the nuclear reaction, the surface 
effects such as absorption of radioactivity on the target wall need to be considered. When these 
gases are used as target materials, the F-18 produced becomes adsorbed onto the target 
chamber walls, and non-radioactive [19F]F2 gas, which retrieves the bound F-18 activity by isotopic 
exchange upon heating, has to be used to obtain the radioactive [18F]F2 from the gas target 
efficiently. As a result, the F-18 becomes extensively diluted with F-19 so that only relatively low 
specific activities for [18F]F2 can be obtained. The use of special target materials such as glass 
traps the F-18 on the surface of the target wall from which it can be flushed out with water. This 
procedure, which is not often used because of low yields due to the small cross section, however, 
would provide [18F]fluoride as an anion instead of [18F]F2. Later, Solin et al. developed a more 
controlled [18F]F2 production method.24 [18F]fluoride produced by bombardment of O-18 enriched 
water, which can be obtained with higher SA, was converted to [18F]CH3F by nucleophilic 
substitution on CH3I. Isolated [18F]CH3F was trapped into stainless steel loop at liquid nitrogen 
temperature, and charged with known, small amount of [19F]F2 carrier gas diluted with neon. 
Isotopic exchange between radiolabeled fluoromethane and unlabeled fluorine gas was effected 
by excitation via electric discharge through gas, which resulted in [18F]F2 with more than 50 
GBq/μmol (>1350 Ci/mmol). Although using larger amount of carrier gas provided higher yield of 
[18F]F2, SA value was in inverse proportion to it. The [18F]F2 gas obtained from a target is typically 
converted to less reactive and more selective reagents, such as acetyl hypofluorite 
(CH3CO2[18F]F), fluorosulfonamide (R-SO2-NR[18F]F) and SelectfluorTM. Major target radiotracers 
produced by electrophilic radiofluorination include 6-[18F]FDOPA, a neurotransmitter analog that 
permits the investigation of presynaptic dopamine neurotransmission.25 Very high SA material is 




Scheme 1.3. Radiosynthesis of 6-[18F]FDOPA from an organotin precursor by electrophilic 
fluorination. 
D. Preparation of Nucleophilic [18F]Fluoride 
Since electrophilic fluorination is not a suitable method to synthesize radiotracers with high 
SAs, examples of radiotracer synthesis with electrophilic method are quite limited. [18F]Fluoride 
incorporation by nucleophilic substitution, on the other hand, is the most widely used and the most 
practical method for radiotracer synthesis with high SAs. However, nucleophilicity of aqueous 
[18F]fluoride obtained directly from the cyclotron is so poor that it actually cannot be used; this is 
due to the extensive solvation of the anion by strong hydrogen bonds formed with water 
molecules. Therefore, before it is used, [18F]fluoride needs to be activated, and the key is the 
addition of an appropriate base to afford a reactive, organic-soluble fluoride source. Traditionally, 
slightly soluble inorganic fluoride sources, such as K[18F]F or Cs[18F]F, were utilized for 
radiosynthesis, but the low solubility of these salts caused he reactions to be slow and inefficient. 
Nowadays, activation using phase-transfer-catalysts26 has greatly improved the solubility of the 
fluoride salt in organic media, and thus has improved the radiochemical yields of substitution 
reactions. The most popular method employs the 4,7,13,16,21,24-hexaoxa-1,10-
diazabicyclo[8.8.8]hexacosane (K222 or Kryptofix 222, Figure 1.3, 4). This aminopolyether can 
form a strong complex with the potassium counter cation of K[18F]F effectively, so that highly 
nucleophilic, organic soluble fluoride anion is produced. Other cations including Cs, Rb and 
quaternary ammonium are also commonly used, and the choice of cation often plays a critical 
role in the success of a particular F-18 radiolabeling. Because it is difficult to predict the optimal 
fluoride source in advance, however, researchers typically have to screen the reaction conditions 
extensively.  
Typically, activation/drying of [18F]fluoride is done by repeated azeotropic distillation with 
acetonitrile in the presence of base and phase-transfer catalysts under a stream of inert gas (N2 
or Ar) at elevated temperature (80 – 100 oC). Recently, the use of anion exchange cartridges has 
been widely employed because it enables the expensive O-18 enriched water to be recycled. In 
this method, [18F]fluoride from the target water is first trapped on the cartridge and the remaining 
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O-18 target water is recovered. Then, the bound F-18 activity is eluted with a basic solution which 
often contains water, otherwise the fluoride would not be eluted. Consequently, this method also 
requires a careful drying step after elution of the activity.  
 
Figure 1.3. Structure of 4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane (K222 or 
Kryptofix 222). 
Nucleophilic substitutions are done mostly at aliphatic positions. If the target radiotracer 
has aliphatic fluorine, or there is a position where fluorine can replace another element without 
disrupting its biological activity, then the corresponding substitutable precursor can be prepared. 
The leaving groups include sulfonates (trifluoromethane-, p-toluene-, p-,m-nitrobenzene-, or 
methane-) and halides (iodo-, bromo-, chloro-, and fluoro). Sulfonate esters are especially 
valuable because they can be synthesized easily from the corresponding alcohol. F-18 
incorporation is done with organic soluble fluorides in polar aprotic solvents at high temperature. 
Even though this method is not perfect because it sometimes results in hydrolysis or β-elimination, 
it is still one of the most reliable F-18 radiolabeling methods, and one which is applied to the 
synthesis of [18F]FDG (Scheme 1.4.) 
 
Scheme 1.4. Radiosynthesis of 2-[18F]fluoro-2-deoxy-D-glucose by nucleophilic substitution. 
Nucleophilic aromatic substitution can afford Ar-F compounds which are found in many 
drugs. However, it is feasible to do this only when the aromatic ring is electron deficient. Strong 
electron-withdrawing groups are utilized to enhance the electrophilicity of the ring, and nitro and 
quaternary ammonium are used as leaving groups.   
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V. Fluorination on Electron-Rich Aromatic Rings 
A. Background 
While there are many method for labeling with F-18 at aliphatic position or on electron-
deficient aromatic rings, there were essentially no reliable methods to radiolabel electron-rich 
aromatic rings, such as phenols, with F-18 with high specific activity. The widely used Balz-
Schiemann reaction is a reliable method to form Ar-F bonds with F-19 fluoride, but it does not 
work with trace levels of fluoride ion, and most aryldiazonium salts used in this reaction (e.g., BF4-
, PF6-) contain F-19 fluoride that dilutes the F-18 by exchange under the high temperatures 
required for the reaction.  One of the early radiolabeling attempts on an electron-rich aromatic 
ring utilized [18F]F2 gas as an electrophilic fluorinating agent. However, as mentioned above, the 
production of [18F]F2 gas requires addition of carrier gas [19F]F2 gas, which results in low specific 
activity due to dilution of fluorine-18 with non-radioactive fluorine-19.  Recently, several 
methodologies were developed which enable fluorination on electron-rich aromatic rings using 
fluoride ion (F-) as fluorine source, especially using organometallic chemistry.  
B. Recent Development of Transition Metal-Mediated Fluorination on Aromatic Rings. 
One pioneering example of transition-metal mediated Ar-F formation on electron-rich 
aromatic ring was developed in Buchwald group, in which they described C-F bond formation by 
reductive elimination of an Aryl-PdII-F intermediate induced by a bulky monodentate ligand, 
BrettPhos.27 The significance of this work was not only formation of the C-F bond but also using 
cesium fluoride as fluorine source, because [18F]CsF is a commonly used fluoride source in F-18 
labeling. However, this method still has limitations for F-18 radiolabeling (so that radiolabeling 
based on this method has not reported yet). First, even at elevated temperature (80 oC~110 oC), 
the reaction time is more than 12 hours, which is six time longer than the half-life of fluorine-18, 
so that only 1.6% of the initial level of fluorine-18 will remain at completion of the reaction. 
Furthermore, regioisomeric products were formed in some cases. For example, p-tolyl triflate 
forms mixture of m-, p-fluorotoluene (36:64) and p-anisole triflate also forms m-, p-fluoroanisole 
(70:30) under the conditions described. Later, they found an evidence of formation of Pd-arene 






Scheme 1.5. Formation of ArF from LPdAr(F): catalytic conversion of aryl triflates to aryl 
fluorides.27 
 
In 2011, Furuya et al. reported a novel strategy to change fluoride ion from a nucleophile 
to an electrophile utilizing a high-valent Pd(IV) complex;29 this expanded the application of 
transition metal-catalyzed fluorination to fluorine-18 radiolabeling. The complex 5 is designed 
based upon  the following considerations; (i) the palladium center bears three positive charges to 
capture negatively charged fluoride, (ii) the oxidation state of the palladium center is +IV, so that 
the complex acts as electron acceptor, (iii) multidentate ligands are used to improve the stability 
of the complex toward undesired reductive elimination, (iv) an octahedral complex was chosen to 
avoid undesired nucleophilic attack, and (v) aromatic ligands are utilized to avoid nucleophilic 
attack on the carbon or nitrogen atoms that attached to palladium. The formation of [18F]Pd(IV) 
fluoride was prepared fairly simple way, where complex 5 was treated with a conventionally 
prepared [18F]fluoride solution to form an electrophilic [18F]fluorinating agent within 10 minutes at 
room temperature.  Following addition of the nucleophile, another palladium complex as 
substrate, [18F]fluorine incorporation occurred at the desired position in decent yield. The 
challenges of this method, however, are associated with instability of Pd(IV) complexes 5 and its 
intermediates, which requires extensive careful handling during the F-18 labeling process. 
 
Scheme 1.6. Umpolung strategy with high-oxidation-state Pd.29 
The following year, the same group reported a nickel-mediated late-stage fluorination 
method.30 This method improved F-18 radiolabeling in terms of simplicity and ease, compared 
with Pd precedent. When the water-stable Ni(II) complex shown in Scheme 1.7 was mixed with 
aqueous [18F]fluoride (conventional drying or addition of excess base) and an oxidant (in situ 
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oxidation of metal center to capture fluoride and promote reductive elimination), the [18F]ArF 
product was produced quickly with radiochemical yields comparable to those obtained with the 
Pd(IV)-mediated method. This method again showed the possibility of radiofluorination of other 
substrates of interest to the radiochemistry community, but the preparation of the Ni complex 
requires special experimental set-ups and very careful handling due to difficulty of using Ni(COD)2 
that is the starting material of the complex.  
 
Scheme 1.7. Nickel mediated F-18 radiolabeling on arenes.30 
More recently, copper mediated C-F bond formation methods have been studied by 
different research groups. The first example was by the Hartwig group; they studied Cu(II) 
mediated Ar-F bond formation using AgF as fluoride source.31 They demonstrated wide substrate 
scope, including arenes with electron donating and withdrawing groups, para-, meta- and ortho-
substituents. However, this reaction requires high temperature and long reaction time; also, the 
counter cation of fluoride source, Ag, is very important for the success of this chemistry, by 
enabling halide exchange between iodine and fluorine on the copper metal center. Unfortunately, 
our attempts to apply this method to F-18 labeling failed, due to the difficulty of forming [18F]AgF 
from F-18 water. 
 
Scheme 1.8. Cupper mediated fluorination on arenes from ArI.31 
Following the Hartwig study, the Sanford group developed a method for Ar-F formation 
from arylboronic acids using KF as fluoride source.32 Although the best results were obtained 
when arytrifluoroboronates was used as precursors (70%), other arylborates including pinacol 
borate (57%), MIDA boronate (9%), or arylboronic acid (3%) produced the fluorinated arenes but 
in reduced yield. Nevertheless, since an excess amount of fluoride ion is required when using the 
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pinacol borate, it was thought that the pinacol borate needed to be converted to trifluoroborate to 
undergo desired fluorination. Furthermore, it is expected that in F-18 radiolabeling, use of the 
trifluoroborate precursor result in a product of low specific activity because of isotopic exchange 
(19F/18F). Later, the Gouverneur group developed CuII mediated aryl C-F bond formation with F-
18 from arylborate esters.33 The significant improvement of this work is that they could utilize the 
easily produced [18F]KF/K222 as a fluoride source.33  
 
Scheme 1.9. Copper mediated F-18 radiolabeling on arenes from arylborates.33  
C. Hypervalent Iodine Precursors 
Diaryliodonium salts are commonly used as precursors for nucleophilic fluorination on 
arenes, and a number of F-18 radiolabeling studies were undertaken to prepare PET radiotracers 
using these precursors. In many cases, this approach proved to be troublesome due to low 
reactivity of fluoride ion toward hypervalent iodine substrate, with conversions requiring elevated 
reaction temperatures, as well as due to the poor selectivity for fluoride ion attack between the 
two aryl groups bound to the iodine center. This was a particular problem when attack on electron-
rich arenes was desired for F-18 labeling. Ichiishi et al. discovered that the Cu-catalyzed method 
overcame these disadvantages of diaryliodonium precursors.34 This method took advantage of 
the high electrophilic nature of Ar2I+, which enables the precursor to undergo oxidative addition to 
Cu under mild conditions. Furthermore, it is known that the oxidative addition of diaryl iodonium 
salts to Cu is sterically controlled, with Cu insertion occurring between the hypervalent iodine and 
the smaller aryl group. Therefore, using the hindered mesityl ring as the leaving group and KF as 
fluoride source, efficient Ar-F formation was achieved under mild conditions. It was not surprising 
that this transformation was easily applied to F-18 radiolabeling,35 because the conditions are 
suitable for fluorine-18 radiosyntheses, with KF used as fluoride source, reaction proceeding 
under fairly mild conditions and fluoride incorporation being rapid.35 However, the possibility of 
low SA should be considered through because this method works best for F-18 labeling when the 
BF4- salt was used. Isotopic exchange (19F/18F) is likely, especially if prolonged reaction times 
and/or higher temperatures are needed for the completion of the reaction. Unfortunately, the more 




Scheme 1.10. Copper mediated fluorination of [Mes]-I+-Ar salt.34,35 
More recently, a novel class of hypervalent iodine precursors for F-18 radiolabeling of 
arenes, iodonium ylides, was discovered by Liang et al.36 Diaryliodonium salts often undergo 
decomposition or disproportionation, which makes it difficult for them to be purified or stored for 
long time periods. However, the spirocyclic Iodine (III) precursor shown in Scheme 1.11 proved 
to be stable. The stabilizing effect is thought to be due to electron donation from the adjacent 
carbonyls to the positively charged iodine(III) center of the ylide, yet it still enables the 
addition/reductive elimination process to take place as has been invoked to occur with the 
diaryliodonium salt or other iodine(III) species that results in the direct and regioselective F-18 
radiolabeling on arenes. Furthermore, this spirocyclic iodonium ylide precursor expands the 
substrate scope significantly. For instance, the copper-mediated iodonium salt method showed 
good regioselectivity, but the substrate has to be sterically less hindered than mesitylene to obtain 
good regioselectivity. Iodonium ylide, however, is able to label even sterically hindered positions 
(ortho-dimethyl or ortho-diisopropyl). Moreover, no transition metals are needed for this chemistry; 
this offers significant advantages because residual levels of such metals is always a potential 
problem in the preparation of clinically used agents, especially when such metals are used in a 




Scheme 1.11. Spirocyclic iodonium ylides for Ar-F formation36 
 
VI. F-18 Radiolabeling Based on Fluorophilic Elements: Al, B, Si. 
A. Background. 
The radiolabeling methods discussed so far are all based on C-F bond formation using 
nucleophilic fluoride as the fluorine source, and recent developments in F-18 radiolabeling 
methods have improved RCY and SA, which has enabled access to a variety of radiotracers in 
practical use. However, in many cases of PET radiotracer synthesis, F-18 radiolabeling is still 
suffering from various difficulties due to the nature of C-F bond and the challenges of its formation. 
This is why other radionuclides are used instead of F-18 due to the ease of their incorporation 
into other tracer molecules. To overcome this disadvantages inherent in labeling molecules with 
F-18 on carbon, the development of methods using “fluorophilic” precursors, which include 
aluminium, boron and silicon, have been getting more attention recent years. Fluorine readily 
forms very strong bonds with these elements (Table 1.3)  
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Table 1.3. Bond Dissociation Energy with Fluorine 







B. Aluminium-18F Chemistry 
The chelation of radiometals is a widely applied methodology to radiolabel the compounds 
of interest from research level to clinical use, and recently much effort has been placed on 
developing F-18 radiolabeling methodology of peptides using some elements having high affinity 
for fluoride ion.  
The utilization of a novel pentadentate bifunctional chelator, 1,4,7-triazacyclononane-1,4-
diacetate (NODA), to coordinate Al3+ ion provided an effective scaffold to capture aqueous 
[18F]fluoride anion in a single, high yielding step (55-89%) within 15 minutes at 110 oC. More 
importantly, the corresponding bioconjugates (10) exhibited exceptional stability, with no 
defluorination being observed after 4 h in human serum at 37 oC (Scheme 1.12).12 This technically 
simple labeling procedure has led to the development of labeling kits,13 similar to those used with 
99mTc, that will aid in streamlining reactions and facilitate product purification and isolation.14 As a 
result, this has enabled rapid and reproducible labeling of peptides in high RCYs and specific 
activities through a simple, one-step process to afford 18F-labeled products that are compliable 
with good manufacturing practices (GMPs) and ready for patient injection within 30 minutes. Of 
these three new strategies, the Al-18F approach is the most recently introduced and while still in 
its infancy within the development process, possesses the greatest likelihood of benchtop-to-




Scheme 1.12. One-step chelation of aqueous [18F]fluoride anion with Al3+-NODA.12 
C. Boron-18F Chemistry 
Organoboranes, particularly alkyl- and alkynylboranes, are unstable under atmospheric 
conditions, so that the handling of these reagents is extremely difficult. In 1960s, potassium 
organotrifluoroborates were discovered as alternatives for trivalent borates.37,38 These reagents 
exhibit significant stabilities toward nucleophiles, air and water, so that they can be handled 
without special precautions.  Furthermore, they maintain their high reactivity, especially in 
palladium-mediated cross coupling reactions.39  
The translation of these precursors to tracer level chemistry with F-18, however, has only 
recently been realized. Ting and coworkers were the first to report the F-18 labeling of aryl boronic 
esters, under carrier-added conditions, to afford [18F]-aryltrifluoroborates.40 Similar to aluminum 
chemistry, the attractive features of the boron-based labeling methods are its simple, one-step 
procedure, and capability to operate in aqueous media, which makes this method applicable for 
labeling of water-soluble biomolecules and significantly simplifies the overall labeling protocol by 
removing the time-consuming drying step of fluoride. The first practical example which took 
advantage of this chemistry was the radiosynthesis of a biotinylated [18F]-p-
aminophenyltrifluoroborate 10. In this study, in vivo evaluations showed that there was no skeletal 
uptake of radioactivity, indicating high stability of the B-F bond.  
 
Scheme 1.13. Preparation of [18F]aryltrifluoroborates 12 from aqueous [18F]fluoride ion. 
 
One of the issues of aryltrifluoroborates is its high lipophilicity, which can elevate the logP 
of a whole compound, and thus alter its pharmacokinetic profile. Recently, Liu and coworkers 
discovered a new class of organotrifluoroborate compounds, alkylammonio-methyltrifluoroborate 
(AMBF3). This zwitterionic molecules has high stability toward hydrolysis, presumably due to the 
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stabilizing effect of adjacent positive charge. In physiological environments no or negligible bone 
uptake was observed in vivo. Furthermore, the advantage of this strategy also includes the ease 
of preparation. F-18 incorporation was performed by 19F-18F isotopic exchange with aqueous 
[18F]fluoride, and since no byproduct was formed during the labeling, HPLC purification was very 
simple; thus, overall tracer synthesis can be done within 30 minutes. However, concern about the 
expected low SA of the final radiotracers still remain due to the nature of the isotopic exchange 
method used for incorporating the radionuclide. 
 
Figure 1.4. General structure of alkylammoniomethyltrifluoroborates (AMBF3). 
 
D. Silicon-18F Chemistry 
Chemists have taken advantages of strong silicon-fluoride bonds for deprotection of silyl 
ethers of the corresponding alcohols. Interestingly, only recently have radiochemists been able to 
develop silicon-based radiosynthetic methods for fluorine-18. The first report of Si-18F bond 
labeling was with [18F]fluorotrimethylsilane; this product, however, exhibited low stability in vivo 
experiments in rats, showing significant bone uptake of radioactivity. Later, similar to their B-18F 
work, Ting investigated the potential of tetrafluorosilicates as imaging agent,40 but the requirement 
for carrier addition and the poor stability of the F-18 incorporated product were significant 
limitations of this method.  
 
Scheme 1.14. Preparation of [18F]aryltrifluorosilane 14 from aqueous [18F]fluoride ion. 
 
In an attempt to obtain better insight into the stabilities of Si-18F bond. Hohne and 
coworkers utilized density functional theory (DFT) models to estimate the hydrolytic stability of 
silicon-based precursors.41 This work suggested that highly bulky substituents on silicon, namely 
two tert-butyl groups, might enhance the stability of the silane precursors with leaving groups of 
alkoxy, hydroxy, or hydride. Using relatively simple substrates, they also demonstrated that 
[18F]fluoride could be incorporated in up to 96% RCY within 20 minutes in the presence of a 
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catalytic amount of acetic acid. The hydrolytic stability test of the corresponding [18F]fluorosilanes 
also showed a strong correlation with the DFT analysis, proving as well that sterically hindered 
organofluorosilanes have good resistance to hydrolysis under physiological conditions.  
This approach was utilized for radiolabeling more structurally complex biomolecules, such 
as peptides, through an Si-18F bond. Labeling proceeded in sufficiently high RCYs and SAs 
within15 minutes. However, this methods still has significant disadvantages: The requirement for 
dry [18F]fluoride and the formation of products with low effective specific activity. Radiolabeling of 
these silane precursors has to be performed under dry conditions; in contrast, the previously 
discussed B-18F chemistry enables F-18 incorporation under aqueous conditions. Furthermore, 
when large, complex substrate was used, the exchange of hydrogen with fluoride atom does not 
provide sufficient difference structurally or electronically between substrate and product. This 
causes troublesome isolations, and often results in contamination of the desired radiolabeled 
product with chemically similar unlabeled impurities which are likely to compete with the tracer for 
binding to the target. In essence, the products have low effective specific activity.   
 
Scheme 1.15. Preparation of [18F]aryltrifluorosilane 16 from aqueous [18F]fluoride ion. 
 
 
VII. Concluding Introductory Remarks 
Herein, we described the current status of F-18 radiochemistry for the preparation of PET 
radiotracers. Fluorine-18 has preferred characteristics as a PET radionuclide, which are low 
nuclear energy that guarantees high resolution of images, a long enough half-life of 109 minutes 
that provides sufficient time for preparation and for good target tissue uptake and contrast 
development, a strong bond to C, Al, B, and Si that gives stable radiotracers, and a small size 
that does not or only minimally disturbs biological activity of tracers. The ideal F-18 
radiofluorination method would afford the desired radiotracers by a simple procedure, under mild 
conditions, producing products rapidly in high RCYs and SAs.   
[18F]FDG is most widely used and studied PET radiotracer, and approximately 90% of PET 
scans executed worldwide utilize [18F]FDG. However, it is not universally useful and has some 
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important disadvantages, including high uptake in certain organs, such as brain, which causes 
low contrast of imaging and nonselective uptake in noncancerous conditions (i.e., infection, 
inflammation). Therefore, there are many medical areas in which radiotracers are needed that 
can provide informative images of normal physiology and disease pathology. The development 
of novel radiotracers relies heavily on the establishment of reliable radiolabeling methods capable 
of producing labeled agents in high RCYs and with high SAs, and despite considerable advances 
in many areas, there are still “missing links” in radiochemistry. 
Most high SA PET radiotracers are prepared by nucleophilic substitution, especially at 
alkyl positions. For example, FDG is radiolabeled by [18F]fluoride replacement of a triflate or other 
sulfonyl groups. In case of aromatic fluorination, the practical substitution methods available 
nowadays are limited to electron-deficient arenes. For the electron-rich aromatics, electrophilic 
fluorination methods can be used, but due to practical problems connected with the production of 
electrophilic fluorination reagents, such as [18F]F2, require F-19 carrier addition; so, radiotracers 
with sufficiently high SAs for imaging low abundance receptor targets cannot be prepared by this 
method. Recently, much effort has been focused on the development of novel Ar-F formation 
methods, mainly in the organometallic field, and some success using fluoride (F-) as fluorine 
source have been reported, including examples applied to F-18 radiolabeling. However, those 
methods still need to be developed further in terms of substrate scope (without 
protection/deprotection), practicality (stable metal complex substrates or reagents) or mildness of 
reaction condition (proceeding room temperature).  
The use of “fluorophilic” elements, including B, Al and Si, is another area which has been 
developed recently. The size of the moiety to which the F-18 atom is attached is usually large, so 
use of this approach to label small molecule probes generally leads to loss of affinity for the 
receptor targets. By contrast, large biomolecules, such as peptides or proteins, can often be 
labeled by this approach without compromising affinity, and thus can take advantage of quick and 
efficient fluoride incorporation. Recent studies proved the potential of silicon-fluoride to be 
sufficiently stable in physiological environments, and several labs reported the use of Si-F labeling 
for the preparation of radiotracers. One of the limitations of silicon-fluorine chemistry is there is 
no method to incorporate fluoride without the burdensome drying step during which the needed 
excess base can harm the compounds of interest. The drying step can be avoided by labeling 
through boron. 
Overall, even though the demand of PET imaging has been increasing, the development 
of PET tracer preparation methods has not been sufficient to satisfy all of the requirements for F-
18 radiolabeling needed to prepare a large variety of promising PET radiotracer candidates. 
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Therefore, it is very important to develop novel methods that will fill important “missing links” in F-
18 radiochemistry by exploring unprecedented approaches for F-18 incorporation that will be 
efficient, mild, simple and rapid. The exploration of some new methods for F-18 labeling are 
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Facile Preparation of ortho-Fluorophenols from Non-aromatic Precursors and  
Investigation of Application to Fluorine-18 Labeling  
I. Introduction 
A. Demand for F-18 Labeled ortho-Fluorophenols 
The phenol function is ubiquitous in both naturally occurring and synthetic bioactive 
compounds. In drugs, the phenolic function is often substituted with fluorine because fluorine 
substitution, particularly at the ortho position, enhances receptor target binding affinity, perhaps 
by adjusting the phenol pKa or because of fluorine’s hydrogen-bond acceptor characteristics; in 
vivo potency can also be increased by extending the drug clearance profile and increasing drug 
exposure by blocking ortho-hydroxylation metabolism directly by the placement of fluorine at the 
site of metabolism, or indirectly through fluorine’s electron withdrawing nature.1 An example is 2-
[18F]fluoroestradiol (2, Figure 2.1), which is an alternative PET radiotracer for 16α-
[18F]fluoroestradiol (16α-[18F]FES, 1).  
16α-[18F]FES is the most widely used PET imaging radiotracer for detection of estrogen 
receptor-positive breast cancer, and it is being evaluated in a multi-center trial to predict patient 
response to hormone therapy.2–4 While 16α-FES is widely used, there is still a demand for ER 
binding radiotracers that have even higher affinity and a better pharmacokinetic profile, to obtain 
clearer and more informative images.5–10 F-18 labeling of 2-fluoroestradiol, however, is 
challenging because of the high SA required to image the low concentrations of the estrogen 
receptor in breast tumors, and because of the electron-rich nature of the phenol ring. Thus, the 
method that our group reported in 1996 is only reported preparative method for 2-
[18F]fluoroestradiol,5 and this route required introduction of an electron withdrawing group, a 6-
keto group, to allow nucleophilic substitution on the phenolic ring; this ketone then had to be 
removed after the F-18 incorporation, a step that is time consuming and reduces the overall yield 










Scheme 2.1. Radiosynthesis of 2-[18F]fluoroestradiol5 
B. Electrophilic Fluorination on Phenols 
In Chapter I, we discussed aromatic fluorination reactions that are applicable for F-18 
radiolabeling. However, some fluorination methods, even with F-19, prove to be challenging and 
thus are still underdeveloped. Fluorination of electron-rich aromatic rings, such as phenols, with 
F-19 is usually accomplished by direct electrophilic fluorination of the corresponding phenols 
using N-fluoro compounds.11 This method, however, has significant disadvantages, such as poor 
regioselectivity, over fluorination and the need for harsh conditions. Typically, electrophilic 
fluorinating agents give mixtures of both ortho- and para-fluorophenols, and these products are, 
in many cases, difficult to separate (Table 2.1).11 For example, fluorination of phenol using the 
most common reagent of the class, Selectfluor™, proceeds slowly, and produces ortho- and para-




Table 2.1. Direct electrophilic fluorinations on phenol13 
 
reagent solvent temp Time Conversion 6:7:8 
SelectfluorTM CH3CN MW, 
150oC 
1 h 24% 
(6+7) 
2:1:- 
FP-OTf TCE 100oC 24 h 75% 51:18:6 
2,4-Cl2FP-OTf CH2Cl2 reflux 5 h 73% 60:18:7 
2,2’-bisFP-BF4 CH3CN reflux 8h 77% 39:33:5 
2-SO3-4,6-(CF3)2FP CH2Cl2 rt 13h 87% 84:1:0 
2-SO3FP TCE reflux 1.5 h 81% 100:0:0 
2-SO3-6-ClFP TCE 100oC 49h 95% 100:0:0 
 
Substituted N-fluoropyridinium-2-sulfates were found to be better ortho selective reagents 
than non-substituted ones,14,15 and it was suggested that the regioselectivity can be explained by 
hydrogen bond formation between sulfonate and phenolic alcohol and also by π-π interaction of 
substrate and reagents (Figure 2.2) This was supported by the fact that utilizing protic solvents or 
addition of acid significantly reduced the selectivity. However, the reactivity of these reagents is 
low, so that either high temperatures or extended reaction times are required for the completion 




Figure 2.2. Proposed transition state of fluorination of phenol with N-pyridinium-2-sulfate 
Furthermore, the preparation of 2-fluoroestradiol is more complicated due to the difficulty 
of distinguishing between the two ortho positions (C-2 and C-4) of A-ring. N-fluoropyridinium 
compounds fluorinate ortho positions, and, even worse, Selectofluor™ favors ipso fluorination at 
C-10 position.16,17 In fact, no known fluorination reagent is capable of showing any selectivity 
between C-2 and C-4, and the separation of these regioisomers requires further transformations 
(Scheme 2.2).  
 
Scheme 2.2. 2-Fluoroestrdiol preparation from estrone using N-fluoropyridine 
As already discussed, there is significant demand for development of more convenient, 
efficient and rapid synthetic methods for arene fluorination, especially electron-rich aromatic rings, 
such as phenols. Each of the recently emerged methods has both advantages and 
disadvantages. Due to the short half-life of F-18 (<2 hours), the overall labeling procedure, which 
includes [18F]fluoride preparation, incorporation of fluoride, work-up/purification and further 
transformations, such as deprotection, should be rapid. Most of the approaches to fluorophenols, 
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however, require protection of phenolic alcohol group, because its acidity diminishes the 
nucleophilicity of fluoride; so, the protecting group has to be removed after fluoride incorporation. 
This is particularly disadvantageous for F-18 labeling because of the short half-life of this isotope.  
C. Non-aromatic precursor: Diazo Compounds  
ortho-Quinonediazide 14 (Scheme 2.3) was chosen as the model compound for this study 
because it is a mimic of the AB ring system of estradiol, and thus represents electron-rich aromatic 
rings in general. ortho-Quinonediazides such as 14 can be readily isolated and are generally well 
behaved materials.18  Remarkably, ortho-quinonediazides have been known since 1896,19,20 and 
they are even found in a natural product, cremeomycin.21 They are used as carbene precursors 
for insertion reactions or Wolff rearrangement in synthesis22–24 and they are components of 
photoresists for offset printing.25  
We believed ortho-quinonediazides could be used as precursors of o-fluorophenols 
(Scheme 2.3). Treatment with various sources of HF (HF-pyridine complexes; dry Bu4NF and 
acid), we believed, should effect the equivalent of a Balz-Schiemann reaction, but this is unlikely 
to be useful on the tracer scale for an interesting reason. In studies of alkene additions to effect 
radiofluorination, our group found that HF addition was remarkably sluggish and unsuitable for F-
18 radiolabeling. The high level of acid required for electrophilic addition protonated the fluoride 
ion, so it was no longer nucleophilic; in essence, fluoride acted as a better (harder) base towards 
the hard acid proton than did the softer alkene π system. The solution was to replace the proton 
electrophile with a soft electrophile, namely Br+ or I+. Thus, for the alkene addition reaction, we 
found that halofluorination, but not hydrofluorination, worked well for F-18 radiolabeling.26–29 
Therefore, we planned to treat the ortho-quinonediazide 14 with soft electrophiles, together with 
sources of anhydrous fluoride ion. This should produce the corresponding α-fluoro-α-
halocyclohexadienone 15. Subsequent zinc-mediated reduction should then generate the o-
fluorophenol (16) directly, without the need for phenol deprotection. 
 






A. ortho-Quinonediazide as Precursor for o-Fluorophenol Preparation 
o-Quinonediazide 14 was readily prepared from β-tetralol (17, Scheme 2.4). Since the C-
1 position of the tetralol is most reactive position toward electrophilic substitution, direct nitration 
under conventional conditions gave predominantly 1-nitro-2-tetralol. To avoid this, we protected 
the C-1 position; bromination of 2-tetralol with 1,3-dibromo-5,5-dimethylhidantoin (DBDMH) 
afforded 1-bromo-2-tetralol. Nitration of the bromo tetralol occurred selectively at the C-3 position, 
and subsequent Pd-catalyzed hydrogenation reduced the nitro group to the amine (aniline) and 
at the same time removed the bromine at C-1 reductively. The resulting amino phenol was 
obtained as hydrobromide salt 19, which was used without further purification. Diazotization was 
accomplished with isoamylnitrite, and the resulting diazonium salt was neutralized to obtain ortho-
quinone diazide 14 as dark brown-colored syrup.23 This o-quinone diazide was sufficiently stable 
that it could be purified by silica gel column chromatography, and it was stored at low temperature 
in a dark to prevent photochemical reactions such as the Wolf rearrangement.24 
 
 
Scheme 2.4. Synthesis of ortho-quinone azide. Reagents and conditions: (a) NBS (1.0 eq), DMF, 
rt, 18h, 81%, (b) HNO3, AcOH, H2O, 0 °C, 48%, (c) H2 (10 psi), 10% Pd/C, THF, MeOH, rt, 21h, 91%, 
(d) Isoamylnitrite (4.0 eq.), MeOH, 0 °C; NaHCO3, H2O; sat. NaHCO3 aq., 52%. 
 
Halofluorination of the diazo functional group was conducted with electrophiles in the 
presence of fluoride ion. Although a great variety of conditions (combination of four electrophiles, 
three fluoride sources and six solvents) was investigated, unfortunately, none of these could 
successfully produce the fluorine-incorporated product. Based on observation of these reactions, 
it was apparent that no nitrogen gas was released during the course of the reaction; this was 
expected as a result of halofluorination reaction of the diazo functional group. Analysis of the 
reaction products suggested that substitution by the electrophile was occurring on the ring, 
presumably next to diazo group, rather than replacing the diazo group (20, Scheme 2.5). In 
investigations of o-quinone diazides,18 Schweig et al. found that the one of the isomeric structures 
of an o-quinone diazide, notably 1,2,3-benzoxadiazole 21, was detected by UV and IR 
spectroscopy, which suggested that the benzoxadiazole is actually the dominant species present 
in non-polar solvents; a polar solvent, such as 1,1,1,3,3,3-hexafuoro-2-propanol (HFIP), shifts the 
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equilibrium toward o-quinone diazide. In the case of halofluorination of o-quinonediazides, 
however, even a polar solvent such as DMF did not direct bromination to the diazo group, and 
protic solvents were not useful because they reduce the nucleophilicity of fluoride through strong 
hydrogen bonding, so they compete with fluoride for nucleophilic attack. Thus, o-quinonediazides 
proved not to be appropriate precursors for fluorination, and a modification of the approach was 
required.  
 
Scheme 2.5. Attempts at halofluorination of an ortho-quinone diazide and the structure of the 
isomeric benzo-oxadiazole. 
 
B. α-Diazocyclohexenones as Alternative Precursors for the Halofluorination Approach to o-
Fluorophenols  
The problem with the o-quinone diazide as a precursor for o-fluorophenol synthesis is 
associated with its aromaticity; so, we conceived of an alternative diazo compound, an α-
diazocyclohexenone 22, which can be derived from the corresponding α,β-unsaturated 
cyclohexenone. By removing one double bond from the quinone diazide, the compound was no 
longer aromatic, which should limit electrophilic halide substitution on the ring, yet the α-
diazocarbonyl group would still be capable of undergoing halofluorination. In principle, α-
diazoketones can undergo the previously mentioned isomerization to form the corresponding 
1,2,3-oxadiazoles. However, although 1,2,3-triazoles and thiadiazoles are widely known and well 
characterized, the appearance of 1,2,3-oxadiazoles in the literature is limited. Sydnones are 
known, but they should be considered different from typical 1,2,3-oxadiazoles because of their 
36 
 
unique mesoionic characteristics.30 Because the N-O bond of an oxadiazole is known to be very 
weak,31 we believe that the diazoketone structure of an α-diazocyclohexenone would be dominant.  
Bromofluorination of certain α-diazocarbonyl compounds is known in which α-diazo esters 
are transformed into α-bromo-α-fluoro esters using NBS as electrophile and HF-pyridine complex 
as fluoride source.32 Thus, this encouraged us to believe that starting from α-diazo-
cyclohexenones, halofluorination should yield α-fluoro-α-haloketones. In contrast to the quinone 
diazide that we first considered as precursors, the α-diazocyclohexenone precursor is even more 
attractive because it has the same oxidation state as the final target compound, the o-fluorophenol. 
So, in principle base-promoted hydrohalide elimination will lead directly to an α-
fluorocyclohexadiene, which will undergo immediate tautomerization to give produce the o-
fluorophenol without the need for a separate reduction step. This simplified sequence would 
guarantees the tolerance of reduction-sensitive functional groups.  
 
Scheme 2.6. Strategy of o-fluorophenol formation from cyclic-α-diazoketones 
C. Preparation of α-Diazocyclohexenones 
We chose α-diazoketone 22 as the model compound. Preparation of 22 is shown in 
Scheme 2.7. There are several different methods to prepare α,β-unsaturated cyclohexenones, 
including ring construction and partial reduction of phenols; we chose to prepare diazoketone 22 
by ring construction (Robinson annulation) from cyclohexanone. Cyclohexanone was converted 
into enamine 24, and 1,4-addition to methylvinylketone and acid-promoted dehydration afforded 
tetralin 25 in 66% yield. This method was easily scalable up to 5 g. Although our first attempt to 
introduce an α-diazo functional group by activation of α-position with a formyl group resulted low 
yield of the desired α-diazoketone, activation with a trifluoroacetyl group followed by diazo transfer 
from a sulfonyl azide yielded the target α-diazoketone effectively. p-Toluenesulfonyl azide is 
commonly used as a diazo transfer agent, but the byproduct, p-toluenesulfonamide proved 
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difficult to separate from the product diazoketone. Thus, methanesulfonyl azide was utilized, and 
the methanesulfonamide could be removed with a weak base wash. The α-diazoketone was 
sufficiently stable on silica gel to be isolated by conventional column purification, and it could be 
stored at low temperature for at least six months without decomposition.  
 
Scheme 2.7. Synthesis of α-diazocyclohexenone 22 
D. Electrophile Screening  
 Using α-diazoketone 22 as the substrate, the electrophile for halofluorination was 
investigated. It is known from a literature report that reaction of α-diazoesters in the presence of 
Et3N•3HF produces the α-bromo-α-fluoroester.32 Gratifyingly, we found that reaction of α-
diazoketone 22 with N-bromosuccinimide (NBS) in the presence of Et3N•3HF produced the o-
fluorophenol product. Other bromine electrophiles, such as N-bromoacetamide (NBA) or 1,3-
dibromo-5,5-dimethylhydantoin (DBDMH), also worked (Table 2.2, entry 1-3), although yields 
were not high. We avoided NBS, however, because we found that a succinimide-incorporated 
product could be detected in another substrate (β-diazo-α-tetralone, not described in this thesis). 
Although bromine electrophiles are efficient at promoting this reaction, other halide electrophiles 
(chlorine and iodine) were not capable of effecting fluorine incorporation even though the diazo 
function reacted with them equally well, releasing nitrogen gas (entry 4-6). Interestingly, 
SelectfluorTM produces the desired compound very efficiently, but, while useful for synthesizing 
unlabeled F-19 substituted products, it is not an appropriate electrophile for the F-18 labeling, 
because the electrophile itself contains F-19 and would lower specific activity by isotope dilution. 
Nevertheless, regioselective fluorination of phenols is sufficiently challenging that this approach 
affords a convenient and practical means for o-fluorophenol preparation. Details of cold o-
fluorophenol syntheses from diazo ketones are presented later in this chapter.  
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Table 2.2. Electrophile scope of halofluorination of α-diazoketone 
 







1 NBA rt/10 min. 15 4 56 
2 DBDMHb rt/10 min. 14 5 65 
3 NBA rt/10 min. 17 4 59 
4 NCS rt/10 min.  100  
5 I2 rt/10 min.  43 11 
6 NIS rt/10 min.    
7c SelectfluorTM rt/20 min. 80   
8c,d SelectfluorTM rt/20 min. 60   
Halofluorination reaction was quenched with water, and extracted with EtOAc, and elimination 
with DBU followed immediately after that. aYields are determined by 1H and 19F NMR using 
fluorobenzene as the internal standard. b0.55eq was used due to its two reactive bromine. 
cacetnitrile was used as solvent. dwithout Et3N•3HF. 
 
E. Fluoride Source Screening 
In F-18 radiolabeling, the most commonly used fluoride sources includes alkali metal salts 
(NaF, KF, CsF) and quaternary ammonium salts (n-Bu4NF [TBAF], Et4NF, Me4NF), and actually, 
examples of the use of triethylamine trihydrofluoride (Et3N•3HF) for radiolabeling are limited to 
carrier-added conditions that give very low specific activities.33,34,35 As a practical matter, it is very 
important to screen fluoride sources for each radiofluorination method to ascertain which F-18 
precursor is suitable for the radiolabeling method.  As we already discussed, Et3N•3HF and 
Pyr•9HF are good sources of fluoride (Table 2.3, entry 1,2). The more practical fluoride sources 
typically used for radiolabeling, however, did not result in the incorporation of fluoride into the 
product after the attempted bromofluorination step. CsF and KF had solubility issues in organic 
solvent, as had been expected; even addition of 18-crown-6 did not help solubility at all. With 
TBAF•3H2O, interestingly but unfortunately, the diazoketone failed to react with the electrophile, 
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so unreacted starting material was recovered almost quantitatively, even after reaction at elevated 
temperatures (entry 5). This was thought due to the possible hydrogen bond formation between 
residual water and fluoride, which reduces the nucleophilicity of the fluoride. Although this can 
explain inefficiency of fluorine incorporation, the reasons for the loss of reactivity of the 
diazoketone is still unknown.  
We decided to explore a practical drying method for TBAF. Anhydrous TBAF is 
commercially available only as a solution, and the solid form is very hygroscopic. To further 
complicate matters, during extensive drying, Hoffman elimination occurs to produce tributylamine 
and 1-butene. Kim et al. discovered the complex of TBAF with tert-butyl alcohol (TBAF(t-BuOH)4) 
as a practical way to obtain a source of dry fluoride.36 An X-ray crystal structure of the complex 
shows that four molecules of t-BuOH surround a single fluoride ion, which presumably protects 
the fluoride ion from water. Furthermore, they demonstrated the improved efficiency of TBAF(t-
BuOH)4 compared to conventionally prepared anhydrous TBAF solution in THF toward alkyl 
substitution reaction, indicating that the complex not only has higher nucleophilicity but also has 
reduced basicity, which was suggested by less formation of the β-elimination product. The 
preparation of TBAF(t-BuOH)4 is reasonably simple: TBAF•3H2O is dissolved in a t-BuOH/hexane 
mixture at high temperature and when the mixture is cooled, it gives crystals of the complex. This 
anhydrous TBAF complex proved to be an efficient fluoride source for bromofluorination. The α-
diazoketone reacted with electrophiles with presence of TBAF(t-BuOH)4  rapidly, producing o-
fluorophenol after DBU treatment (entry 6).  
Unfortunately, formation of the complex in this manner is not practical when using trace 
amounts of fluoride for F-18 labeling at high specific activity. In reality, for F-18 radiolabeling, 
[18F]fluoride is obtained as an aqueous solution from the cyclotron target, and extensive drying 
steps are required, as already discussed in Chapter I. Thus, a more practical drying method for 
F-18 labeling was investigated using a small amount of TBAF•3H2O as starting material, with the 
aim of forming the complex and drying it in situ. To TBAF•3H2O was added dry t-BuOH and the 
mixture was heated; presumably. TBAF(t-BuOH)4 is formed at this point; then azeotropic drying 
with CH3CN removed water and replaced it with t-BuOH. The TBAF prepared this manner was as 
efficient as the preformed complex (entry 7). The product yield was not sufficient at this point, but 
it was confirmed that even substoichiometric amount of TBAF still provide fluorinated product in 
comparable yield, an important result that suggests the fluoride incorporation still persists when 
fluoride ion concentrations are very low, at the tracer level, as would be the case for F-18 labeling 
at high specific activity.   
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Table 2.3. Fluoride scope of halofluorination of -diazoketone  
 







1 Et3N•3HF CH2Cl2 14 5 65 
2a HF•Pyr CH2Cl2. 27 5 68 
3 CsF CH3CN ND   
4 KFb CH2Cl2 ND   
5c TBAF•3H2O CH2Cl2 NR   
6 TBAF(t-BuOH)d CH2Cl2 7   
7 TBAF(t-BuOH)e CH2Cl2 6   
8 TBAF(t-BuOH)e,f CH2Cl2 4   
Yields are determined by 1H and 19F NMR using fluorobenzene as the internal standard. 
Halofluorination reaction was quenched with water, and extracted with EtOAc, and elimination 
step followed immediately after that. ND; product not detected with 19F NMR. NR; no reaction. 
aDiazoketone was added to the mixture of HF•Pyr and DBDMH due to reactivity of diazoketone 
with HF.Pyr. bwith presence of 18-crown-6. cat 40 oC for 1 hr.  dreformed complex. eformed and 
dried in situ. f0.9 equiv. of TBAF used 
 
F. Reaction Condition Screening (solvent, temperature) 
The solvent was also optimized. The effect of solvent cannot be ignored in fluorine 
chemistry, because it can greatly affect the reactivity of the fluoride ion. In general, polar aprotic 
high-boiling-point solvents are preferred in F-18 labeling, especially in nucleophilic substitution 
reactions; these solvent solubilize the fluoride ion, sustain its nucleophilicity and allow execution 
of reactions at elevated temperature if necessary. The main concern in our diazoketone chemistry 
is the formation of byproducts. We hypothesized that an undesired pathway of reaction in the 
attempted halofluorination might involve a β-elimination of a proton from the diazonium 
intermediate, before fluoride incorporation (Scheme 2.8). We hoped that with proper solvent 
choice, it might be able to stabilize the cationic intermediate by solvation without reducing 
41 
 
nucleophilicity of fluoride ion. Also, conducting reactions at lower temperature might prolong the 
life-time of the reactive intermediate.  
The result of our solvent/temperature screening is shown in Table 2.4. Reactions in non-
polar solvents (entry 1, 2) produce the o-fluorophenol. Although diethyl ether worked as well as 
CH2Cl2, THF produced no fluorine-incorporated product (entry 3). Polar aprotic solvents did not 
give any desired product (entry 4-6). DMSO and DMF are often solvents chosen for F-18 labeling. 
However, they are usually not considered suitable for electrophilic reactions or oxidations, due to 
their reactivity towards the reagents used under those conditions. The α-diazoketone was 
sufficiently reactive toward DBDMH at temperatures as low as -20 °C. However, cooling the 
reaction did not improve product yield to any degree. Thus, using CH2Cl2 and Et2O as solvents, 
between 0 °C and room temperature gave the best yields of halofluorination using fluoride ion as 
the source of fluorine.  
  
Scheme 2.8. Fluorination and elimination from diazonium intermediate  
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Table 2.4. Solvent and temperature scope of halofluorination of α-diazoketone 
 







1 CH2Cl2 25 °C 14 5 65 
2a Et2O 25 °C 27 5 68 
3 THF 25 °C ND   
4 CH3CN 25 °C ND   
5c DMF 25 °C NR   
6 DMSO 25 °C 7   
7 CH2Cl2 0 °C 22   
8 Et2O 0 °C 29   
9 CH2Cl2 -20 °C 26   
10 Et2O -20 °C 12   
Yields are determined by 1H and 19F NMR using fluorobenzene as the internal standard. 
Halofluorination reaction was quenched with water, and extracted with EtOAc, and elimination 
step followed immediately after that. ND; product not detected with 19F NMR. NR; no reaction. 
aDiazoketone was added to the mixture of HF.Pyr and DBDMH due to reactivity of diazoketone 
with HF.Pyr. bwith presence of 18-crown-6. cat 40 °C for 1 hr.  dreformed complex. eformed and 
dried in situ. f0.9 equiv. of TBAF used.  
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G. Hydrobromide Elimination 
Thus far, we have discussed only the first step of the halofluorination reaction. After this 
first step, the α-bromo-α-fluoroketone 23 is formed; then, base treatment causes hydrobromide 
elimination followed by tautomerization to afford o-fluorophenol 16. To investigate conditions for 
the elimination step, isolation of the α-bromo-α-fluoroketone by silica gel column chromatography 
was attempted, but this intermediate turned out to be very unstable on silica gel. Consequently, 
no α-bromo-α-fluoroketone was eluted, only the fluorophenol and the bromophenol. The formation 
of the intermediate was confirmed, however, by 19F NMR, in which two doublet of doublet peaks 
appeared at chemical shifts of -112 ppm and -117 ppm. These signals correspond to each of the 
two diastereomers (with fluorine in the equatorial and the axial positions) and are distinct from the 
o-fluorophenol (δ -145). Thus, the crude mixture from the first step was used to screen conditions 
for the second step condition, and yields were determined by 19F NMR (Table 2.5).  
DBU could effect hydrobromide elimination efficiently (entry 1), whereas other commonly 
used bases, such as triethylamine or pyridine, resulted in no reaction, the bromofluoroketone 
remaining intact (entry 4, 5). Silver salts were also investigated because it was thought that the 
high affinity of silver ion for bromine (higher than for fluorine) might effect a chemoselective 
elimination of HBr in preference to HF. Although when combined with DBU, the silver salt 
efficiently eliminated HBr (entry 2), silver salt by itself did not effect elimination, even after 
extended reaction times (entry 3). Based on our prior observation of the instability of the 
bromofluoroketone during our attempts to isolate this intermediate by silica gel column 
chromatography, silica gel was added to the reaction mixture of halofluorination, and it efficiently 
produced the o-fluorophenol. Thus, for the elimination, DBU or silica gel treatment turned out to 
be optimal.   
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Table 2.5. Elimination reaction condition screening. 
 
Entry bReagent temp., time Yielda 
1 DBU rt, 20 min. 20% 
2 DBU, Ag2O rt, 20 min. 23% 
3 AgOTf rt. 16h 0% 
4 Pyridine 40oC 0% 
5 Et3N 40oC 0% 
6 Silica gel N/A 28% 
aYields were determined by 1H NMR and 19F NMR. bα-bromo-α-fluoroketone (13) was used as the 
reaction mixture of bromofluorination.  
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H. Quantitative Analysis of the Elimination Step 
The product yield of o-fluorophenol obtained thus far from the diazoketone was 30%. We 
wondered whether this relatively low yield might be the result of the competitive elimination of HF 
from the bromofluoroketone, in which case the o-bromophenol would be formed. To investigate 
this, we needed to quantify the amount of bromofluoroketone and especially quantify the content 
of the individual stereoisomers. Even though, as previously described, we were unable to isolate 
these species, we could nevertheless, quantify the formation and elimination of these isomeric 
intermediates by 19F NMR. The identity of the two bromofluoroketone diastereomers was 
assigned based on their coupling constants, the larger one having F axially disposed (19%), and 
smaller an axial Br (11%). 
 
Scheme 2.9. Stereochemistry of bromofluoroketone didastereomers. 
We expected that the elimination of the hydrogen halide from the bromofluoroketone 
would proceed by an E2 process, following strict antiperiplanar geometry. Consequently, we 
anticipated that the yield of the fluorophenol could not exceed that of the intermediate with 
bromine axially disposed (namely 11%). In fact, the fluorophenol is obtained in 25% yield, which 
is 6% greater than the amount of the precursor having fluoride in the “protected” equatorial 
position. This indicates, surprisingly, that some of the o-fluorophenol product is coming from the 
other diastereomer. Thus, the antiperiplanar geometry expected for an E2 elimination is not strictly 
enforced in this elimination. 
This observation also indicates that HF elimination from the intermediated is not the major 
route for forming the o-bromophenol. In fact, we found that the o-bromophenol had already formed 
at the bromofluorination step, though no o-fluorophenol was present at this time. Thus, the 
sequence of reactions appears to be somewhat complex: The first step is the attack of Br+ on the 
diazo group, giving a highly reactive α-bromo-α-diazonium intermediate that then partitions, either 
with fluoride displacing the diazonium group by nucleophilic substitution, giving the 
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bromofluoroketone intermediate, or alternatively, by deprotonation at the β position, leading 
directly to the bromophenol. Further bromination forms dibromophenol 27, presumably by a 
conventional electrophilic aromatic bromination. This sequence of events also explains why no 
bromofluorophenol was observed, and, as noted earlier (entry 8, Table 2.2), in the reactions with 
SelectfluorTM, o-fluorophenol was formed without added fluoride ion.  
 
I. Attempts to Apply the Diazocyclohexenone to o-Fluorophenol Transformation to F-18 
Radiolabeling  
 The highest yield obtained under “cold” reaction condition screening with fluoride ion as 
the only fluorine source is approximately only 30%, which was not sufficient for efficient routine 
o-fluorophenol preparation (although, as discussed below, the reaction with Selectfluor has a 
number of features that make it attractive as a general synthetic method). In the case of fluorine-
18 radiolabeling, this relatively low yield may not be a significant disadvantage. In radiolabeling 
with trace amount of [18F]fluoride ion, product yield in cold chemistry does not always translate 
directly into RCY because the amount of substrate in the radioisotopic synthesis is in great excess 
compared with [18F]fluoride.   
The conditions for the actual radiolabeling with F-18 was based on the results in the cold 
chemistry reactions. The best result obtained in cold chemistry was: DBDMH or NBA as 
electrophile, and CH2Cl2 or Et2O as solvent, so these reagents were tried in the F-18 labeling. 
[18F]Fluoride ion obtained from the cyclotron target water was dried with either K2CO3, K222 or n-
Bu4N.HCO3, azeotropically with acetonitrile added. Bromofluorination was conducted at room 
temperature or at 0 °C. After the release of N2 had ceased, DBU was added to the reaction mixture, 
and it was allowed to stand at room temperature. Although silica gel is also capable of eliminating 
HBr, it was not used to screen reaction conditions in F-18 labeling because the RCY cannot be 
determined correctly due to the absorption of unreacted [18F]fluoride ion onto silica gel.  
Unfortunately, these attempts all failed even with carrier ([19F]fluoride). This was disappointing 
because the carrier-added reaction was identical to cold reaction described above except for the 
addition of F-18 water and presence of excess base. Three possible factors were interfering with 
this reaction: (i) residual water, (ii) excess base and (iii) other substances in the target water, and 
we conducted cold control experiments to see which of these, if any, actually is interfering with 
the fluorine incorporation.   
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Table 2.6. Control reactions for identifying interference. 
 
entry Fluoride and additive Yield of 16a 
1 TBAF.3H2O No reaction 
2 TBAF.(t-BuOH)n 6% 
3 TBAF.(t-BuOH)n + H2O <1% 
4 TBAFb  6% 
5 TBAFb + n-Bu4N.HCO3 <1% 
6c TBAFb + H2O 4% 
7c TBAFb + recovered target water <1% 
aYield was determined by 19F NMR. bTBAF•3H2O was heated in t-BuOH and then dried 
azeotropically with CH3CN three times. 
cWater added TBAF•3H2O was dried azeotropically with 
CH3CN and then heated in t-BuOH followed by azeotropical dyring with CH3CN again.   
The reaction conditions and results are shown in Table 2.6. First, the possibility that 
residual water diminishes the nucleophilicity of fluoride was investigated (entry 1-3). Although 
when hydrate of TBAF was used, the diazoketone did not react with electrophile, t-BuOH complex 
of TBAF produces desired fluorine incorporated compound, as described previously (Table 2.2) 
However, when 5%v/v water was added to an otherwise identical reaction, no fluorine was 
incorporated into product. This is likely due to strong hydrogen bond formation that reduces the 
nucleophilicity of fluoride, meaning that extensive drying of the fluoride ion is critical. Second, the 
effect of excess base was examined (entry 4, 5). To evaluate this, two identical experiments were 
conducted, with the only difference being that excess n-Bu4N.HCO3 was added to one of them 
(entry 5). It turned out the one to which excess base was added afforded only trace amounts of 
product.  
Finally, we conducted two more experiment, one with MiliQ water and another with 
decayed target water collected at the cyclotron facility F-18 production line (entry 6, 7). After drying 
with t-BuOH and acetonitrile, these preparations were added to the diazoketone solution, followed 
by the addition of DBDMH. Interestingly, the one with decayed target water added afforded only 
trace amount of product, whereas the one with purified water gave the desired product with the 
expected yield. This indicates that some substance is present in the decayed water that interferes 
with the reaction by reducing nucleophilicity of fluoride or by inactivating diazoketone.  
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Although the components of F-18 water produced by proton bombardment of the cyclotron 
target is poorly characterized, some radioactive analysis data show that it contains some 
radioactive metals which are introduced by bombardment of the metal material used to fabricate 
the foil or beam entry point for the target, and these metal ions are released into the target water. 
The most commonly used target foil is very strong material, called Havar alloy, which consist of 
Co, Ni, Cr and others, and some of these metals can form metal carbenoids when reacting with 
diazo functional groups. The element analysis (ICP-MS) unveiled that the decayed water contains 
various cations that include not only alkali metals, such as K, Na, Li, but also some metals possibly 
liberated from target foil. Therefore, we needed to develop a method that removes metal cations, 
does not require excess base, and enables production of dry, reactive fluoride.  
Table 2.7. Element analysis (ICP-MS) of recovered F-18 water* 
Element Mass ppm mg/L pmol/L 
Si 28 20.557 734 
K 39 4.474 115 
Be 9 2.69 298 
Li 7 0.64 91.4 
Co 59 0.303 5.14 
Na 23 0.284 12.3 
Ni 58 0.184 3.17 
Cr 52 0.08 1.5 
Zn 64 0.055 0.86 
Ca 40 0.05 1.3 
*Recovered [18O]H2O was collected after 18F water from cyclotron 
was passed through anion exchange cartridge (QMA). The sample 
was analyzed without dilution.  
J. Ethylenediamine Tetraacetate-TetrakisTetrabutylammonium Salt. 
Ethylenediamine tetraacetate (EDTA) is a chelating agent for heavy metals, with which it 
forms strong complexes, and it is widely used to sequester or remove metals from solution. 
However, the solubility of EDTA is quite low, so it is used as a sodium salt that is readily soluble 
in aqueous media. EDTA is soluble in only a few solvents, and only limited amounts of EDTA can 
be dissolved in a few organic solvents.  On the other hand, tetrabutylammonium salts, in general, 
are commonly used as a phase-transfer catalyst due to their high solubility in organic media, even 
though they bear a positive charge. We conceived of the EDTA tetrabutylammonium (TBA) salt 
as an organic soluble metal chelating agent. In principle, when this EDTA-TBA salt captures a 
metal cation, it releases tetrabutylammonium ion which now can be pared with fluoride, forming 
TBAF in situ. This appears to be ideal because it not only removes metal cations, but in doing so 
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it also forms a common chemical species, TBAF, that is used as a fluoride source in F-18 labeling 
without the need for the addition of excess base that can cause side reactions in general F-18 
radiochemistry. This reagent turned out to very efficient in promoting the halofluorination reaction 
of the α-diazocyclohexenone using CoF2, CrF2, NiF2 as fluoride sources. In general, fluoride salts 
are barely soluble in organic solvents, and some metal fluoride salts are insoluble even in aqueous 
media. However, when the EDTA-TBA salt was present, CoF2, CrF2 and NiF2 were all solubilized 
in CH3CN-MeOH, and by using this solution after a drying protocol, fluoride incorporation was 
confirmed, with the o-fluorophenol being formed in comparable yield to that obtained with 
traditional fluoride sources. Thus, ETDA-TBA salts were capable of solubilizing fluoride salts, and 
they were efficient in promoting diazoketone halofluorination.  
 
Scheme 2.10. EDTA-TBA salt and its application to bromofluorination of diazoketone 
K. Radiochemsitry Using EDTA-TBA4 Salt. 
F-18 water from cyclotron was added to EDTA-TBA4 salt, and at this point, presumably 
metal cations form complexes with EDTA, and [18F]TBAF is released into the solution, which is 
followed by stepwise drying (t-BuOH complexation, and azeotropic distillation with acetonitrile). 
With carrier ([19F]TBAF) added condition, the bromofluorination provided F-18 incorporated 
product that could be observed on both radio-TLC and HPLC (Figure 2.3). Since 
bromofluoroketone 24 could not to be isolated, this result did not directly prove the formation of 
the [18F]fluorobromoketone without use of a cold standard. However, DBU treatment of the 
reaction mixture shifted the radioactive peak on HPLC to a more polar direction, with a retention 









Figure 2.3. HPLC trace of bromofluorination using EDTA.TBA4. Blue line: UV trace, Red line: 
Radio trace. a) bromofluorination reaction mixture. b) elimination reaction with DBU. Radioactive 
product of halofluorination (4.6 minutes, a)) shifted after DBU treatment (3.7 minutes, b)). 
L. Facile o-Fluorophenol Preparative method 
So far, we discussed use of a simple model α-diazocyclohexenone as an F-18 labeling 
precursor. However, this non-aromatic substrate also has great possibilities as a precursor for o-
fluorophenol preparation in general as in cold chemistry. As we already discussed, while direct 
fluorination with electrophilic fluorinating agents is the choice of preparation method for o-
fluorophenol, it is an approach that bears significant drawbacks. The commonly used electrophilic 
fluorinating agents and their products from phenol were listed below (Table 2.8).14,15,37 Most of 





rather harsh. Recently, more ortho selective reagents have been developed, but prolonged 
reaction times and elevated temperatures are still required to obtain desired fluorinated products, 
and the application of these reagents is still limited. 
Table 2.8. Direct electrophilic fluorination of Phenol 
 
Reagent Conditions Yield (%) 
  I II III 
F2 CH3CN/-10 °C/2h 44 23 10 
FP-OTf TCE/100 °C/24h 51 18 6 
Selectfluor CH3CN/150 °C (MW)/1h 16 8 0 
NFSI neat/105 °C/3h 31 25 1 
 TEC/100 °C/49h 58 0 0 
 DCM/rt/13h 84 1 0 
 
 When the phenol precursors are asymmetrically substituted, the regioselectivity issue 
becomes even more complicated. For example, treatment of estradiol or its derivatives with N-
fluoropyridinium produces mixture of 2- and 4-fluoroestradiol, and further transformations are 
required to separate these regioisomers (Table 2.9).   
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Table 2.9. Direct electrophilic fluorination of estradiol and its derivatives15–17,38,39 
 
Substrate Reagent Conditions Yield (%) 
   I II III 
R=H, XY=O Me3PF-OTf DCE/reflux/18h 27 25  
 MeO2PF-OTf DCM/reflux/18h 28 22  
 PF-OTf TCE/reflux/24h 53 20  
 SelectfluorTM H2O/60oC/2-6h   73 
R=H, X=OH, Y=H Cl2PF-OTf CAN/rt/12h 30 30  
 SelectfluorTM    81 
 NFTh    76 
 
Our diazoketone reacted with SelectfluorTM in the presence of Et3N•3HF, producing α,α-
difluoroketone (28), and following HF elimination promoted by DBU then produced o-fluorotetralol 
16, regioselectively and in a good yield (Scheme 2.12, Table 2.10). The sequence of these two 
reactions proceeded rapidly (5 min. and 25 min., respectively) and efficiently (80% overall yield). 
The substrate scope with other diazoketones is shown in Table 2.8. o- and m-butyl-α-




Scheme 2.12. An o-fluorophenol from an α-diazoketone 
 
 
Table 2.10. Substrate scope of o-fluorophenol synthesis from -diazoketone with SelctfluorTMa. 











 Condition: SelectfluorTM (1.2 equiv), Et3N.3HF (2 equiv), CH3CN (0.1 M), rt, 5 min.; DBU (1.5 




2-Fluoroestradiol could also be prepared with this method (Scheme 2.13). Estradiol 3-
methyl ether 29 was partially reduced by Birch reduction condition, resulting in 1,4-
cyclohexadiene 30, which, following hydrolysis/isomerization in acidic media, gave α,β-
unsaturated cyclohexanone 31. After protection of the C-17 OH as the THP ether (32), the diazo 
function was introduced as previously described. The resulting diazoketone precursor 33 was 
readily converted by SelectfluorTM to the corresponding the corresponding α,α-difluoroketone, and 
following DBU treatment and a rapid acidic deprotection of the THP group, 2-fluoroestradiol 2 was 
obtained in a good yield. It is notable that because the diazo function directs the reaction site, this 
method produces no other isomers, whereas conventional electrophilic fluorination methods in 
many cases give mixtures of regioisomers that are troublesome to separate.  
 






In F-18 radiolabeling, most of the special requirements are associated with the short half-
life of fluorine-18. This means that the radiolabeling conditions should be rapid, mild and simple, 
along with furnishing the desired product with high RCYs and SAs. In addition, it is a convenience 
if the precursors are storable and thus available for multiple synthesis over periods of time, and 
are also sufficiently reactive to allow rapid incorporation of [18F]fluoride. One of the concerns about 
the α-diazoketone was its stability. In general, the diazo functional group is known to be highly 
reactive, both thermally and photochemically, prone to forming very reactive species, carbenes, 
which—among other things—undergo Wolf rearrangements to form ketenes that are also highly 
reactive. However, the α-diazocyclohexenones synthesized for this work showed sufficient 
stability that they could be stored for at least several months without decomposition. Once the α-
diazoketone is exposed to various electrophiles, however, it rapidly reacts within minutes, which 
is a major advantage, especially considering the short half-life of the radioactive nuclide, fluorine-
18, that is to be incorporated. One has to be cautious, however, because under acidic conditions, 
the α-diazoketone undergoes rapid decomposition, which means that acidic additives, which are 
needed for effective olefin halofluorination,40 should not be used.  
The fact that the sequence of halofluorination/elimination also produces an o-
bromophenol side product was originally thought to be the result of the elimination of HF instead 
of HBr. However, several results suggest that it was formed not only by elimination of 
hydrofluoride from the α-halo-α-fluoroketone intermediate, but also via different route. A plausible 
mechanism is shown in Scheme 2.14.: The product of electrophile attack of the diazo group 
produces very reactive diazonium species, which preferably undergoes nucleophilic attack by 
fluoride, producing the desired α-bromo-α-fluoroketone (path A). However, there is likely another 
competing reaction, namely deprotonation at the position β to the carbonyl group, which leads to 
the elimination of N2 to produce a cyclohexadiene, which following tautomerization, results in the 
o-bromophenol (path B). This is supported by the fact that after bromofluorination of the 
diazoketone, the full amount of the o-bromophenol is observed even before DBU is added, and 
also that it undergoes further bromination to produce dibromophenol. By contrast, no bromination 
product of o-fluorophenol is detected because the o-fluorophenol is formed only after DBU 
treatment. Another piece of evidence that supports this mechanism is the fact that treatment of 
diazoketone with SelectfluorTM produces o-fluorophenol even without fluoride source. In this case 




Scheme 2.14. Plausible mechanism of halofluorination/elimination 
As already discussed, bromofluorination of α-diazoketone 22 afforded bromofluoroketone 
23 as mixture of two diastereomers, and F-axial being the major isomer. It was thought that from 
the F-axial isomer, HF elimination would be faster than HBr elimination, due to its anti-periplanar 
orientation, and that HF elimination would result in o-bromophenol instead of the desired o-
fluorophenol. DBU treatment of these two diastereomer mixture, however, produced the o-
fluorophenol with a higher yield than the Br axial isomer, which means that at least part of the o-




Scheme 2.15. Mechanism of elimination from α-fluoro-α-bromoketone 
Ortho-fluorination of phenols is still a substantial challenge in fluorination chemistry, 
because it generally shows poor regioselectivity and fairly harsh conditions and extended reaction 
times are required. However, fluorophenol preparation from α-diazocyclohexenones proved to be 
completely regioselective, and the reaction proceeds very quickly.  
Our first attempts at F-18 labeling study from α-diazoketones was not successful, and we 
have found that something in F-18 target water produced during cyclotron bombardment 
interfered with the reaction. Studies suggested that there are some contaminants in F-18 water, 
but our studies so far have not shown which component in the target water and what form of 
[18F]fluoride is responsible for the lack of reactivity. The ICP-MS element analysis date shows that 
there is a significant amount of metal cations in the F-18 water, and most likely, [18F]fluoride exists 
as some sort of alkali or transition metal fluoride.  
In general, fluoride salts have poor solubility, especially in organic solvents, and at low 
temperatures, it is possible that such salts are not completely dissolved. Certain transition metals 
can convert diazo compounds to metal carbenoids, which might not be able to incorporate fluorine 
ion and thus simply degrade the precursor material. The organic-soluble chelator, EDTA-TBA4, 
was discovered and found to be a very efficient phase transfer catalyst. When it is mixed with F-
18 water straight from the cyclotron target, it sequestered the metal cations from the media, and 
at the same time released [18F]TBAF, without the need for the addition of excess base. This is 
beneficial not only for this diazoketone chemistry, but is also likely useful for improving other more 
conventional methods for F-18 labeling that utilize nucleophilic substitution.  
Cyclic α-diazoketones were also found to be efficient precursors for o-fluorophenol 
synthesis with F-19. Since the preexisting diazo functional group directs the site of fluorine 
incorporation, regioisomers are not formed, which is usually the case with typical phenol 
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electrophilic fluorination methods. Moreover, the reaction is complete within 15 minutes at room 
temperature, which is significantly quicker than any of the other conventional methods.  
IV. Conclusion 
In conclusion, we studied a novel approach for fluorine-18 labeling of phenols. α-
Diazocyclohexenones were found to be sufficiently reactive toward bromine electrophile attack, 
which is then followed by nucleophilic attack of fluoride, giving the bromofluorocyclohexenone. 
Subsequent HBr elimination and tautomerization produced the o-fluorophenol. Not only for F-18 
labeling, but also for F-19 substitution, fluorophenol synthesis is challenging due to the poor 
regioselectivity of currently available fluorinating reagents, but by using α-diazoketones as 
precursors, we could successfully prepare o-fluorophenols both rapidly and efficiently. Our current 
focus is on improving the yield of F-18 radiolabeling.   
V. Methods 
Materials 
All reactions are carried out under nitrogen atmosphere with dry solvent using anhydrous 
condition unless otherwise stated. Tetrahydrofuran, diethyl ether, toluene, and dichloromethane 
were dried by the solvent delivery system (SDS) (neutral alumina columns) designed by Meyer. 
Glassware was oven-dried, assembled while hot, and cooled under an inert atmosphere.. 
Reagents were purchased from Aldrich, TCI USA, or Fisher and used without further purification, 
unless otherwise stated. Yields refer to chromatographically and spectroscopically (1H NMR) 
homogeneous materials, unless otherwise stated. Reactions were monitored by thin layer 
chromatography (TLC) carried out on Merck silica gel 60 F254 precoated plates (0.25 mm) using 
UV light or phosphomolybdic acid and heat for visualization. Flash column chromatography was 
performed on Silica P Flash silica gel (40-64 m, 60 Å) from SiliCycle. 1H NMR spectra were 
recorded at 23 °C on Varian Unity-400, Varian Inova-500 or Varian Unity-500 spectrometer and 
are reported in ppm using residual protium as the internal standard (CDCl3,  = 7.26, Acetone-d6, 
 = 2.05, center line, DMSO-d6, = 2.50, center line, CD3CN,  = 1.94, center line, methanol-d6, 
= 3.31, center line, CD2Cl2, = 5.32). The following abbreviations were used to denote the 
multiplicities: s = singlet, d= doublet, t = triplet, q = quintet, dd = doublet of doublets, dt = doublet 
of triplets, td = triplets of doublets, m = multiplet and br = broad signal. Proton-decoupled 13C NMR 
spectra were recorded on a Varian Unity-500 (126 MHz) and Varian Inova-500 (126 MHz) and 
were reported in ppm using solvent as internal standard (CDCl3,  = 77.16, center line, Acetone-
d6,  = 29.84, center line, DMSO-d6, = 39.52, center line, methanol-d6, = 49.00, center line). 
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High resolution mass spectra were obtained at the University of Illinois, School of Chemical 
Sciences Mass Spectrometry laboratory. No-carrier-added [18F]fluoride was produced at 
Washington University Medical School by the 18O(p,n)18F reaction through proton irradiation of 
enriched (95%) [18O]H2O using a RDS111 cyclotron. Screw-cap test tubes used for drying fluoride 
and radiolabeling were purchased from Fisher Scientific (Pyrex No 9825). Radiochemistry 
analysis was perform by HPCL (HPLC: P4000, column: Altima C18, 5 mm, 250mm).For the thin-
layer chromatography (TLC) analysis, EM science Silica Gel 60 F254 TLC plates were purchased 
from Fisher Scientific (Pittsburgh, PA, USA). Radio TLC was accomplished using a Bioscan 200 
imaging scanner (Bioscan, Inc., Washington, DC, USA). Radioactivity was counted with a 





1-Bromo-5,6,7,8-tetrahydronaphthalen-2-ol.41 To a solution of β-tetralol (17) (1.94 g, 13.1 
mmol) in DMF (4 mL), solution of NBS (2.33 g, 13.1 mmol) in DMF (4 mL) was added. The 
resulting mixture was stirred for 18 h at room temperature. The reaction was quenched with water 
and the mixture was extracted with EtOAc. The organic layer was washed with water 4 times (total 
volume 130 mL), and dried over MgSO4. After concentration under vacuum, the residue was 
purified by silica gel column (5% to 10% EtOAc in Hex) to give 2.70 g of white solid in 81% yield: 
1H NMR (500 MHz, CDCl3)  1.70-1.83 (m,4H, C6, C7), 2.65-2.71 (m, 4H, C5, C8), 5.46 (s, 1H, -
OH), 6.81 (d, J =8.3 Hz, 1H, C3), 6.94 (d, J = 8.3 Hz, 1H, C4; 13C NMR (125 MHz, CDCl3)  22.6, 
23.1, 29.2, 30.5. 
 
1-Bromo-3-nitro-5,6,7,8-tetrahydronaphthalen-2-ol (18).41 To the solution of 1-bromo-2-tetralol 
(5.18g) in AcOH (42 mL) and H2O (14 mL), cold conc. HNO3 was added slowly at 0 °C. After 10 
min stirring at 0 °C, the reaction mixture was poured into ice-water, and then extracted with CHCl3 
twice. The combined organic layer was washed with brine and dried over MgSO4. After 
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concentration in vacuo, the residue was purified by silica gel column (50% CHCl3 in Hex) to give 
2.79 g of yellow powder in 45% yield for two steps. 1H NMR (500 MHz, CDCl3)  1.73-1.86 (m, 
4H, C6, C7), 2.75-2.86 (m, 4H, C5, C8), 7.82 (s, 1H, C4), 11.05 (s, 1H, -OH); 13C NMR (125 MHz, 
CDCl3)  22.2, 22.5, 29.3, 31.6, 115.4, 123.3, 125.0, 130.9, 148.5. LRMS(EI) 270.9 (M+): 
HRMS(EI) calcd for C10H10O3NBr (M+) 270.98281, found 270.98440. 
 
3-Hydroxy-5,6,7,8-tetrahydronaphthalen-2-aminium bromide (19). The solution of 1-bromo-
3-nitro-2-tetralol (18) (1.45 g, 5.33 mmol) in THF (15 mL) and MeOH (15 mL) was place in glass 
bottle for Parr hydrogenator, and 10% Pd on carbon (362 mg) was added. The mixture was 
shaken for 20 h under H2 (10 psi) at room temperature. After H2 gas was replaced with N2 gas, 
the catalyst was removed by filtration through Celite and washed with MeOH. The filtrate was 
concentrated in vacuo and the residue was washed with Et2O slurry to give 1.18 g of light gray 
powder in 91% yield. NMR spectra were obtained as free form. 1H NMR (499 MHz, DMSO-d6) δ 
8.63 (s, 0H), 6.32 (s, 0H), 6.27 (s, 0H), 4.23 (s, 1H), 2.60 – 2.38 (m, 1H), 1.65 (p, J = 3.1 Hz, 1H). 
 
3-Diazo-5,6,7,8-tetrahydronaphthalen-2(3H)-one (14). To the solution of aminophenol 
hydrobromide salt (19) (934 mg, 3.84 mmol) in MeOH (11.7 mL), isoamyl nitrite (2.04 mL, 15.4 
mmol, 4.0 eq.) was added at 0 °C. The resulting mixture was stirred further 30 min at 0 °C, and 
30 min at room temperature. The reaction mixture was concentrated under a stream of N2, and 
then water and Et2O were added. The separated organic layer was then washed with sat. aq. 
NaHCO3 solution. The aqueous layer was extracted with Et2O and the combined organic layer 
was washed with H2O and brine, and then dried over MgSO4. After concentration in vacuo, the 
residue was purified by silica gel column (100% EtOAc) to give dark brown oil (348 mg, 52%): 1H 
NMR (500 MHz, CDCl3)  1.68-1.71 (m, 4H, C6, C7), 2.55-2.65 (m, 4H, C5, C8), 6.43(s, 1H, C4), 
6.80 (s, 1H, C1); 13C NMR (125 MHz, CDCl3)  22.0, 22.6, 28.5, 30.4, 109.6, 119.4, 121.9, 126.8, 
151.9, 177.2, LRMS(ESI) 174.9 (M + H), 163.9 (M-N2): HRMS(ESI) calcd for C10H15O (M + H) 





4,4a,5,6,7,8-Hexahydronaphthalen-2(3H)-one (25).42 To a solution of cyclohexanone (5.00 mL, 
48.3 mmol) in benzene (50 mL) was added pyrrolidine (4.76 mL, 58.0 mmol). The resulting mixture 
was refluxed with Dean-Stark trap for 4 hours. After the formation of the enamine (24) was 
confirmed by 1H NMR, the solvent was removed in vacuo, and the supernatant was separated 
from brown precipitate to give 7.45 g of orange oil. To the solution of pyrrolidine enamine in 
benzene (70 mL) was added methyl vinyl ketone (4.10 mL, 49.2 mmol). After the mixture was 
refluxed for 16 hours, buffer solution made up of NaOAc (2.05 g), AcOH (4.1 mL) and H2O (4.1 
mL) was added and refluxing was continued further 4 hours. The organic layer was separated 
and washed with 1M aqueous HCl, sat. NaHCO3, and brine, and dried over MgSO4. After 
concentration, the resulting residue was, then, purified by silica gel column (20% EtOAc in Hex) 
to give 4.56 g of pale yellow oil in 62% yield. : 1H NMR (500 MHz, CDCl3)  1.17 (ddd, J = 25.1, 
13.0, 3.7 Hz, 1H), 1.35 (qt, J = 12.9, 3.7 Hz, 1H), 1.45(qt, J = 13.0, 2.78 Hz, 1H), 1.59 (qt, J =13.4, 
8.9, 4.4 Hz, 1H), 1.76-1.94 (m, 3H), 2.05 (dq, J = 13.6, 5.0 Hz), 2.16-2.19 (m, 1H), 2.22-2.29 (m, 
2H), 2.32-2.42 (m, 2H), 5.77 (s, 1H); 13C NMR (125 MHz, CDCl3)  25.4, 26.8, 29.1, 34.3, 35.5, 
36.4, 37.8, 124.7, 167.3, 200.0, LRMS(ESI) 151 (M + H), 173 (M + Na): HRMS(ESI) calcd for 
C10H15O (M + H) 151.1123, found 151.1118. 
 
 
3-diazo-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (22). To the freshly prepared LDA from 
anhydrous diisopropyl amine (803 mg, 7.91 mmol) and n-butyl lithium (1.6 M in Hex, 4.94 mL, 
7.91 mmol) was added the solution of 25 (990 mg, 6.59 mmol) in 10 mL of THF dropwise over 15 
minutes at -78 °C. The resulting mixture was stirred at the temperature for 1 hour, and then 2,2,2-
trifluoroethyl trifluoroacetate (0.69 mL, 1.00 g, 5.14 mmol) was added rapidly (1 s) by syringe in 
one portion. After 10 min, the reaction mixture was poured into a separatory funnel containing 25 
mL of 5% aqueous HC1 solution and 30 mL of Et2O. The organic layer was separated and the 
aqueous layer was extracted twice with Et2O. The combined organic layer was washed with brine, 
dried over MgSO4 and concentrated in reduced pressure. The resulting residue was dissolved in 
acetonitrile (10 mL) immediately and then, water (0.8 mL, 0.077 g, 4.29 mmol) and Et3N (0.89 mL, 
0.650 g, 6.44 mmol) were added, and a solution of methanesulfonyl azide (0.56 mL, 0.781 g, 6.44 
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mmol) in 15 mL of CH3CN was added dropwise over 20 min. The resulting solution was stirred at 
room temperature for 2.5 h and then concentrated to a volume of ca. 10 mL. The residue was 
diluted with 30 mL of Et2O and washed with three 20-mL portions of 10% aqueous NaOH solution 
and 25 mL of saturated NaCl solution, dried over MgSO4, filtered, and concentrated to afford 0.7 
g of a yellow-orange compound. 1H NMR (500MHz, CDCl3), ), ESI-MS 331.2 (MH+), 313.2, 
251.1; Anal. (exact mass, HRESIMS) calcd for C20H27O4 m/e 331.1902, found 331.1909. 
 
General procedure of halo fluorination/elimination of diazo ketone with triethylamine 
trihydrofluoride complex (Stepwise procedure) To the solution of diazo ketone in CH2Cl2 (0.1 
M) was added Et3N•3HF. Electrophile (1.0 eq.) was added to the mixture. This caused the 
formation of bubbling which typically was complete within a minute. The mixture was stirred for 
10 minutes at room temperature, and then quenched with H2O. The mixture was extracted with 
EtOAc, and the organic layer was washed with H2O and brine, and dried over MgSO4. After the 
removal of solvent in vacuo, the residue was analyzed by 1H and 19F NMR. For the elimination 
step, the whole analyzed mixture was dissolved into THF (0.1 M) and DBU (2.5 equiv.) was added 
and the resulting mixture was stirred at room temperature for 25 minutes. The reaction was 
quenched with 1M HCl aqueous solution, and then extracted with EtOAc twice. The combined 
organic layer was dried and condensed for 1H and 19F NMR analysis. 
General procedure of halo fluorination/elimination of diazo ketone with triethylamine 
trihydrofluoride complex (one-pot procedure). To the solution of diazoketone in CH2Cl2 (0.1 
M) was added Et3N.3HF (3 equiv.). Electrophile (1.0 equiv.) was added to the mixture slowly. After 
bubbling seized (typically took for 1 minutes), DBU (2.5 equiv.) was added to the reaction mixture 
directly, then stirred at room temperature for 25 minutes. The reaction was quenched with 1M HCl 
aqueous solution, then extracted with EtOAc twice. The dried and condensed residue was 
analyzed by 1H, and 19F NMR.  
General procedure of halofluorination of diazoketone with pyridine nonahydrofluoride 
complex. Main difference of the procedure from Et3N complex is the order of the addition of each 
reagent and substrate because the HF-pyridine complex decomposes the α-diazoketone 
producing β-tetralol. Therefore, diazoketone was added to electrophile with the presence of HF-
pyridine complex. HF-pyridine complex was typically used 3 equivalent to diazoketone, which was 
mixed with electrophile (1.0 eq.) in CH2Cl2 (0.1M) and the resulting mixture was allowed to stand 
at rt for 5min. Diazoketone (22) was added to the mixture as a solution in CH2Cl2 (0.3M). This 
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caused the formation of bubbling which typically continued for a minute. The mixture was stirred 
for 10 minutes at room temperature, and then DBU was added the the reaction mixture followed 
by 25 min stirring at room temperature. The reaction was quenched with 1M HCl aq. solution and 
extracted with EtOAc, and the organic layer was washed with H2O and brine, and dried over 
MgSO4. After the removal of solvent in vacuo, the residue was analyzed by NMR. 
 
 
3-Fluoro-5,6,7,8-tetrahydronaphthalen-2-ol (6). 1H NMR (500 MHz, CDCl3)  1.72-1.76 (m, 4H, 
C6,7), 2.63-2.68 (m, 4H, C5,8), 4.85 (bs, 1H, -OH), 6.67 (d, 4JC-F= 9.0 Hz, 1H,C1), 6.74 (d, 3JC-F= 
11.2 Hz, 1H, C4) ; 19C NMR (125 MHz, CDCl3) d -142 (dd), LRMS(ESI) 151 (M + H), 173 (M + 
Na): HRMS(ESI) calcd for C10H15O (M + H) 151.1123, found 151.1118. 
 
 
17β-Hydroxy-4-estrene-3-one (31). To the solution of 30 (611 mg, 2.12 mmol) in MeOH (6 mL), 
1M aq. HCl solution was added. The resulting mixture was refluxed for 2h. After cooling to ambient 
temperature and addition of H2O, the mixture was extracted with Et2O three times. The combined 
organic layer was washed with H2O and brine, and then dried over MgSO4. After concentration in 
vacuo, the residue was purified by silica gel column (50% EtOAc/Hex) to give colorless syrup 
(493 mg, 85%). : 1H NMR (500 MHz, CDCl3)  0.78-0.83 (m, 4H), 0.93-1.08 (m, 3H), 1.18-1.33 
(m, 3H), 1.38-1.60 (m, 3H), 1.76-1.83 (m, 3H), 1.98-2.25 (m, 6H), 2.33-2.45 (m, 2H), 3.61 (t, J = 
8.6 Hz, H), 5.78 (s, 2H) ; 13C NMR (125 MHz, CDCl3) d 11.0, 23.1, 26.0, 26.4, 30.2, 30.5, 35.4, 
36.3, 36.4, 40.3, 42.5, 42.9, 49.5, 49.6, 81.5, 124.3, 167.1, 200.2, LRMS(ESI) 275.2 (M + H), 




17β-Hydroxy-4-estrene-3-one Tributyldimethylsilyl Ether (32). To the solution of 31 (295 mg, 
1.08 mmol) in CH2Cl2 (3 mL), 1,2-dihydropyrrole (1mL) and p-TsOH.H2O (4 mg) was added. The 
resulting mixture was stirred at ambient temperature for 2 hr. The reaction was quenched with sat. 
NaHCO3 aq, then extracted with CH2Cl2 twice. The combined organic layer was washed with brine, 
and then dried over MgSO4. The residue was purified by silica gel column (15% to 20% 
EtOAc/Hex) to give 359 mg of colorless syrup in 93% yield: 1H NMR (500 MHz, CDCl3)   
 
Ethylenediamine tetraacetate tetrakis(tetra-n-butylammonium) (EDTA-TBA4).  
Ethylenediamine tetraacetate (1.46 g, 5.00 mmol) was suspended into 15 mL of MeOH. n-
Bu4NOH (1M in MeOH, 20.0 mL, 200 mmol) was slowly added to the EDTA suspension. The 
resulting mixture was stirred at room temperature until all of the materials were dissolve and got 
clear solution (typically for 2 hours). The solvent was removed in vacuo and resulting residue was 
dry in high-vac pump to give pale yellow oil (7.42 g).  1H NMR (500 MHz, CDCl3) δ 3.37 – 3.22 
(m, 32H), 3.07 (s, 8H), 2.56 (s, 4H), 1.73 – 1.56 (m, 32H), 1.42 (q, J = 7.4 Hz, 32H), 0.97 (t, J = 
7.3 Hz, 48H). 
 
Radiochemical Syntheses 
3-[18F]Fluoro-5,6,7,8-tetrahydronaphthalen-2-ol (6). F-18 water straight from cyclotron (2.45 
mCi) was added to glass tube which contained 1.0 mg of EDTA-TBA4 salt and 2.8 mg of TBAF 
(trihydrate). After addition of 1mL of CH3CN, the solvent was removed under stream of N2 at 104 
oC. To the resulting residue was added 1 mL of t-BuOH and dried under stream of N2 at 104 
oC. 
The activity was further dried azeotropically with CH3CN three times. After cooled to ambient 
temperature, solution of 2.0 mg of diazoketone 22 in CH2Cl2 (200 μL) was added to the activity, 
and then 1.8 mg of DBDMH was added to the diazoketone solution. The mixture was let stand at 





TLC Eluting Conditions: 100% EtOAc 
DONG: 404141.R01 









Region 1 (unreacted [18F]fluoride; 28 mm): 94% 
Region 2 ([18F]fluoroproduct; 55 mm): 6% 
HPLC analysis  
Condition: 70% ACN, 30% H2O flow rate = 1.5 mL/ min, λ = 254 n 
 
Blue: UV trace 
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Resin-Supported Silyl Ester Precursor for Kit-Like Radiolabeling with Fluorine-18 
I. Introduction 
A. Background 
Currently, the preparation of most F-18 PET tracers utilizes late-stage direct [18F]fluoride 
incorporation to compounds of interest. This method, however, is not optimal when the precursor 
bears acidic hydrogens that reduce the nucleophilicity of [18F]fluoride, or has a sensitive functional 
group that does not tolerate in the labeling conditions. This is the case especially when a large 
biomolecule, such as peptide or protein, is to be radiolabeled. Typical labeling with F-18 is done 
by nucleophilic substitution, which usually requires elevated temperature with excess base. 
Despite tremendous efforts in developing mild labeling methodologies, there is no globally 
applicable direct F-18 radiolabeling method for large molecules. In many cases, those compounds 
are labeled by stepwise approaches: radiolabeling on a secondary precursor followed by 
conjugation of this prelabeled precursor to the compounds of interest. The secondary precursor, 
which has both a [18F]fluoride reactive site and a second site for subsequent conjugation, is called 
a prosthetic group. In F-18 labeling, various prosthetic groups have been discovered and utilized 
in tracer preparation (Table 3.1).1–5  
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Table 3.1. Prosthetic group used in F-18 radiolabeling5 










2 alcohols, amines 
 






For radiofluorination of prosthetic groups, nucleophilic substitution on either an alkyl 
position or an electron-deficient aromatic ring is most often used. To conjugate with large 
molecules, alkyl halides, alkyl sulfonates, reactive esters, or aryl aldehydes are used, with 
coupling on an amino group of the peptide or protein. The benefit from recent significant advances 
of click chemistry, clickable functional groups (azide, alkynes), are also seen in many 
publications.6–8 Those methods, however, are still far from ideal. Alkyl fluorides, in general, are 
not stable both under many reaction condition, and they are often degraded or metabolized in 
vivo. Typical byproducts of nucleophilic substitution of alkanes are olefins and alcohols, and 
elimination and hydrolysis occur not only from precursor but also from the fluorinated product. 
Furthermore, high bone uptake of activity is found in many vivo studies, which is usually an 
indication of metabolism that releases [18F]fluoride, which subsequently becomes trapped in bone. 
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Aryl fluorides, on the other hand, form more stable C-F bonds, and thus, prosthetic groups labeled 
with [18F]fluorine at aryl positions, generally show better stability in vivo. However, since aryl 
fluorination is one of the more challenging bond formations, reaction conditions for labeling tend 
to be more aggressive, and reactive functional groups, such as activated esters, cannot tolerate 
those conditions. Therefore, the preparation of F-18 labeled prosthetic groups bearing the fluorine 
on an aryl group, normally take multiple steps.   
Among prosthetic groups, N-succinimyl-4-[18F]fluorobenzoate ([18F]SFB, 3, Table 3.1) is 
one of the most widely used compounds.  The synthetic method for producing [18F]SFB, however, 
is rather complicated (Scheme 3.1).9  To form a stable linkage with large molecules, a reactive 
NHS ester is used to form an amide bond with an amino group of large molecule. However, the 
NHS ester is too reactive to tolerate F-18 labeling conditions, undergoing rapid hydrolysis. This is 
why the NHS ester has to be introduced after F-18 incorporation, leading to a multi-step 
transformation, and each of these steps involves purification, which limits translation of this 
procedure into automated synthesis for clinical use.  
 
Scheme 3.1. Multi-step radiosynthesis of prosthetic group, N-succinimidyl-4-[18F]fluorobenzoate.9 
B. Silicon in F-18 Radiolabeling  
We already discussed silicon chemistry in F-18 radiolabeling in chapter I; this approach to 
radiolabeling relies on the high affinity of silicon toward fluoride ion and the formation of a very 
stable Si-F bond, yet the incorporation proceeds under mild conditions. However, the main 
concern with this class of compounds is their stability under physiological and in vivo conditions. 
Schirrmacher and co-workers demonstrated the stability in biological media of fluorosilanes that 
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are protected by steric hindrance, particularly aryl silanes having with two tert-butyl groups (8).10 
Although the in vitro stability was similar for both mono-t-butyl substituted (9) and di-substituted 
fluorosilanes (10), the in vivo stability was significantly better for the aryl dialkyl species (10). In 
rat, more bone uptake was detected for 9, whereas only little was observed for 10.  
 
 
Figure 3.1. Stability of 18F-fluorosilane in human serum (37.4 °C, pH 7.4-7.6; ○ = 8, ● = 9, ▼ = 
10). RCP = radiochemical purity.10  
Radiolabeling of di-(tert-butyl)fluorosilane was accomplished from the corresponding 
[19F]fluorosilane by isotopic exchange between F-19 and F-18 in high RCY.10–14 One of the 
concerns of this methodology is that low SA is expected to result from the isotopic exchange 
method, as the precursor itself has F-19. As the authors pointed out, to obtain radiolabeled 
product with consistently high SA, a large amount of activity must be used or the amount of 
substrate must be low to guarantee sufficient SA values.10 Later, Mu and co-workers discovered 
a non-isotopic exchange method using di-(tert-butyl)silyl hydride as precursor. Although this 
method utilized chemically different substrates, the resulting F-18 incorporated products turned 
out to be difficult to separate from the silicon hydride precursor, giving the risk of low effective SA 
values. Furthermore, in both of these methods, it is essential to use of dry [18F]fluoride ion as a 
fluoride source to obtain products in high RCYs. The excess base used for drying [18F]fluoride ion 
can cause undesired reactions such as denaturation of peptides or proteins.  Moreover, especially 
in prosthetic group labeling, hydrolysis of the activated esters which are often utilized for 
conjugation can be a serious problem, so that such functional groups have to be built up after the 
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radiolabeling step, leading to cumbersome, inefficient, and time-consuming multi-step 
transformations.    
 
  
Scheme 3.2. F-18 radiolabeling of di(t-butyl)aryl fluorosilane 3.10,15,16 
C. Silyl Ester as F-18 Labeling Precursor 
Our research group discovered a novel precursor for this class of F-18 Si-F labeling 
reagents, silyl esters. The silyl acetates were prepared quantitatively from the corresponding 
chlorosilane 17 by replacement of chloride with acetate, a conversion that can be accomplished 
without decomposition of the NHS ester. The silyl acetate group of this particular compound (18) 
showed excellent stability in protic media; no solvolysis was observed in MeOH or H2O after 5 
days, whereas the NHS ester unit did undergo hydrolysis after 4 hours. More significantly, the 
silyl acetate 18 was also stable on silica gel, so that, unlike other silyl halides, it can be purified 




Scheme 3.3. Preparation of di(tert-butyl)silyl acetate prosthetic group 
 
 
Table 3.2. Stability of silyl acetate 14 in protic solvent. 
 
Solvent time Silyl acetate:AcOH 
MeOH 120 h 100:0 
10% H2O-CH3CN 120 h 100:0 
 
Although the silyl acetate (18) is unexpectedly stable to hydrolysis, gratifyingly it reacted 
with cold fluoride ion within 5 minutes at room temperature. More importantly, the NHS ester unit 
proved to be stable under these reaction conditions, which enabled the F-18 labeled product NHS 
ester to be used directly for further conjugation to large molecules. This stability of silyl esters is 
significant because with conventional silicon precursors used for F-18 labeling, amine-reactive 
functionalities, such as NHS esters, are unstable under the conditions required for fluorination. 
76 
 
Thus, multiple steps are required to prepare the usual prosthetic groups that are F-18 labeled 
directly on the arene ring. On the other hand, the direct single-step preparation of 18, labeled with 
F-18 through silicon, offers great possibilities for achieving rapid, simple and practical methods 
for F-18 radiolabeling of large molecules.  
 
Scheme 3.4. Fluorination of di(tert-butyl)silyl acetate (cold) 
The translation of cold chemistry to F-18 labeling with conventional dry [18F]fluoride 
revealed that even though activity was incorporated efficiently into the product, there were some 
byproducts formed during the reaction. The major byproduct turned out be hydrolyzed product of 
33, which showed that the NHS ester was not sufficiently stable in these conditions; this actually 
does not reflect the results obtained from the cold chemistry. However, when F-18 straight water 
from the cyclotron target was used as [18F]fluoride source without further dying, the labeling 
underwent smoothly without hydrolysis of the NHS ester. This represents a significant 
improvement in F-18 radiochemistry, because 1) it shortens the preparation [18F]fluoride for 
reaction by omitting the drying process, and 2) F-18 labeling was accomplished under extremely 
mild conditions, without excess base.  
D. Kit-Like F-18 Labeling Strategy 
To develop an even more simplified F-18 labeling protocol, the work-up/purification steps 
also need improvement. With trace amounts of [18F]fluoride ion used in typical labeling conditions, 
the isolation of labeled product from unreacted precursor and unlabeled byproducts is critical for 
achieving high effective specific activities. In the previous Si-F methods, for example, the isotopic 
exchange product cannot be separated from unlabeled precursor by any means,10 and the Si-H 
precursor often has a similar retention time on HPLC to the fluorine-labeled product.16 To address 
this problem, we took advantage of a resin-supported method. With the prosthetic group attached 
to the resin through the silyl ester, when the silyl ester is reacted with [18F]fluoride ion, the labeled 
product will be released from resin, with any unreacted precursor remaining on the resin. In 




Figure 3.2. Resin supported silyl ester for simplified F-18 labeling protocol. 
There is another benefit of this methodology, which is the variation of synthetic routes that 
this resin-supported silyl ester enables (Figure 3.3). The preparation of the PET tracer from the 
resin can be divided into two steps: labeling/releasing and conjugation, and the order of these two 
steps are can be reversed. The more straightforward route to label large molecules using the 
resin-bound precursor is to first conjugate the compound of interest onto the resin by reacting an 
amino group of the large molecule onto the NHS ester group of the on-resin precursor. In this 
manner, the large molecule becomes attached to the resin through the attached prosthetic group 
from which it is released during the second, [18F]fluorine-labeling step (conjugation-label/release 
approach). Thereafter, a simple filtration will, in principle, provide the tracer ready to inject into 
animals or patients. Even though the conditions for labeling on the resin are very mild, some large 
biomolecules may not be stable. In this case, the alternate label/release-conjugation route can be 
followed. [18F]Fluoride treatment of the resin-bound prosthetic group will release F-18 labeled 
prosthetic group 20, which can also be obtained without purification, and then optimal conjugation 




Figure 3.3. Two approaches to prepare [18F]fluorine labeled peptides from a resin-supported silyl 
ester precursor. 
Overall, attachment of the silyl ester onto the resin provides significant advantages for 
fluorine-18 radiolabeling. There is always great demand for simple, efficient and rapid labeling 
methods, but currently, there is no widely applicable method, especially for large molecules such 
as peptides and proteins. With the overall attributes of a rapid, efficient reaction that is tolerant of 
water, coupled with a significantly simplified work-up and purification procedure, we believe that 
the resin-supported silyl ester method for F-18 labeling that we have developed could have a 
major impact on fluorine radiochemistry.   
II. Results and Discussion  
A. Resin Preparation 
The resin-supported silyl ester could be prepared in a similar manner to the silyl acetate: 
(a) reaction of a silyl chloride with COOH-terminated resin, and (b) copper-free click chemistry 
with DBCO (dibenzocylooctyne)-modified silyl compound and azide-terminated beads (Scheme 
3.5). 4-(Chloro-di-(t-butyl))silylbenzoic acid N-hydroxysuccinimide ester (17) was loaded onto the 
COOH-terminated beads in 98% yield. Alternatively, the DBCO group was introduced onto the 
silyl group by the reaction of compound 17 and DBCO-COOH in the presence of Et3N. Azide-
functionalized beads were synthesized by coupling the carboxy group on the resin with α-amino-
ω-azido-tetraethylene glycol. Compound 24 was loaded on the azide-functionalized beads in the 
CH2Cl2-THF (1:1, v/v/) at rt in 96% loading yield.  
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Scheme 3.5. Preparation of resin-supported silyl ester by: (a) direct loading and (b) copper-free 
click, and cold fluorination of resin 25 with TBAF. 
The reactivity of the resin for fluorination in cold chemistry was tested using resin 25. After 
the resin was swelled with CH2Cl2 and [19F]TBAF•3H2O was added, 1H and 19F NMR analysis of 
supernatant showed only fluorosilane product without detection of any hydrolysis of the NHS 
ester.  
B. Fluorine-18 Labeling of Resin-Supported Silyl Ester by the Dry Method 
F-18 labeling of the resin was conducted first by the conventional dry fluoride method. 
Typical bases such as with K2CO3/K222 or n-Bu4N•HCO3 were used to prepare dry [18F]fluoride. 
Although the labeled product was obtained in good RCYs, some labeled byproducts were also 
produced; the addition of various solvents did not help to reduce the formation of the byproducts. 
This result is not surprising because our previous studies showed that the silyl acetate also 
produced radioactive byproducts even though no byproduct formation was found in the cold 




Figure 3.4. Radio-HPLC of the [18F]fluorination of resin 25 with [18F]TBAF in DMSO. Product 
elutes at 5.26 min, with the remaining other 18F-products being undetermined. 
 
C. Fluorine-18 Labeling of Resin-Supported Silyl Ester by the Wet Method 
One of the benefits of silyl esters as precursors is their reactivity with F-18 water obtained 
straight from the cyclotron target. This is a great advantage, because avoiding the drying step is 
both convenient and time-saving, and the reaction conditions are milder because there is no need 
to add base. First, the resin was swelled with acetonitrile, and F-18 water was then added to the 
suspension (CH3CN:F-18 water = 5:1). After 30 minutes at room temperature, 82% of [18F]fluoride 
ion was incorporated, and radio HPLC analysis revealed the formation of significantly lower 
amounts of labeled byproducts. The RCY was unexpectedly high (82%), compared with the silyl 
acetate radiofluorination (0% RCY, rt, 10 minutes).17  
 
Figure 3.5. Radio-HPLC of the [18F]fluorination of resin 25 with F-18 water in CH3CN. Product 
elutes at 5.26 min with the remaining other 18F-products being undetermined 
Even though use of wet conditions in acetonitrile reduced formation of labeled byproducts, 
for the development of kit-like methods, even formation of small amounts of byproduct should be 
avoided. In general, the solvent plays significant role in F-18 radiolabeling, and thus solvent 
optimization was conducted. Among the polar aprotic solvents tested, DMSO showed best result 
in both RCY and radiochemical purity (Table 3.3, entry 2 and Figure 3.6). Although heating 
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increased the RCY and shortened the reaction time, the radiochemical purity was reduced by 
elevating the temperature (entry 2, 4, 5). The conclusion is that the reactions in DMSO at room 
temperature are the optimal conditions. Remarkably, under none of the wet conditions we 
explored was any hydrolysis of the NHS ester observed.  
Table 3.3. Solvent scope of F-18 labeling of the resin supported silyl ester 24. 
 
entry solvent temp/time RCY purity 
1 CH3CN rt/30 min 82% 86% 
2 DMSO rt/30min 93% >98% 
3 DMF rt/25 min 91% 92% 
4 DMSO 50 °C/10 min 90% 94% 
5 DMSO 100 °C/5 min 98% 91% 
Reaction condition; solvent:F-18 water = 5:1. RCY was determined by radio-TLC and purity was 








Figure 3.6. HPLC traces of radiofluorination of resin 25 DMSO at room temperature for 30 min; 
(a) UV trace; co-injected with cold standard 20. (b) radio trace.  
 
D. F-18 Radiolabeling of Small Molecule-Supported on Resin 
To examine the utility of the resin-supported silyl ester for labeling of small molecules, we 
prepared and loaded an estradiol analogue onto the resin. Ethynylestradiol (EE) derivative 26 
was conjugated with DBCO-terminated silyl ester 24, followed by a copper-free click reaction to 
form resin-supported EE. Wet radio fluorination in DMSO at 70 °C yielded labeled product in 41% 
RCY after 10 minutes (Reaction at room temperature gave only a 21% RCY after 30 minutes). 
Even though higher temperatures were required, no byproduct was observed upon radio-HPLC. 
Remarkably, in this radiolabeling, the two hydroxyl groups in estradiol (C-3 and C-17) were not 
protected, avoiding a cumbersome protection -deprotection sequence which is usually essential 
to maintain the nucleophilicity of [18F]fluoride ion. Thus, the ability to radiolabel with [18F]fluoride 
ion without protection of groups with labile hydrogens can greatly simplify the routes of tracer by 





Scheme 3.6. Preparation and F-18 labeling of resin supported estradiol analogue and radio-
HPLC trace of F-18 labeling. 
E. F-18 Radiolabeling of RGD Peptide. 
Radiolabeling of an RGD peptide utilizing the resin-supported silyl ester was also 
examined. The preparation of resin-supported RGD peptide was done in the same manner as 
previously mentioned for the estradiol analogue. The RCY after 10 minutes at room temperature 
reached 50%. However, a radioactive byproduct was formed during the labeling. At this point, the 
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structure of the byproduct is unknown, but it is obvious that this particular peptide is not fully stable 
under these conditions. 
 
 
Scheme 3.7. F-18 labeling of resin supported RGD-peptide and radio-HPLC trace of the reaction. 
31 was eluted at 7.7 minutes and unknown byproduct was eluted at 7.9 minutes. 
 
As discussed previously, there is another route that can be used to prepare labeled 
peptides from resin 25, the label/release–conjugation route. Prosthetic group 21 was labeled and 
released from the resin, and after simple filtration, the solution of 21 was used directly for the 
conjugation step. In either, DMF or MeOH as the conjugation solvent, the RGD-peptide was 
successfully labeled. Although the conjugation conditions still need to be optimized as unreacted 
21 still remained, it should be noted that none of the labeled byproduct that formed in direct 








Scheme 3.8. F-18 labeling of RGD-peptide by label/release-conjugation route. (a) UV trace of 
conjugation with cold standard co-injected. (b) Radio-HPLC trace of conjugation reaction. 15.3 
minutes peak is unreacted prosthetic group 21. 
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F. Non-radioactive Byproduct: Silyl Alcohol Formation 
Thus far, we have found that the resin-supported silyl ester method has a great potential 
to enable kit-like radiotracer synthesis by skipping time-consuming drying and purification steps. 
However, a non-radioactive byproduct was formed during the label/release step, which turned out 
to be hydrolysis product of silyl ester, silyl alcohol 33. It was confirmed that the hydrolysis was 
occurring during the labeling, not during the storage of the resin, because the amount of 33 
increased over the course of reaction. The formation of silanol 33 is potentially a concern for kit-
like methodology because separation of this byproduct from the labeled compound by HPLC 
purification would be time consuming.  
 
 
Figure 3.7. Hydrolysis product of silyl ester, silyl alcohol 33 and HPLC (UV) or label/release 
reaction of resin. 33 is eluted at 2.9 minutes. 
Although the mechanism of hydrolysis of the silyl ester is unclear, we hypothesized that it 
was due to the nucleophilic attack of a water molecule on the carbonyl carbon, whereas fluoride 
ion attacks silicon directly. Since it appeared that the sites of water and fluoride ion attack are 
different, we thought that it might be possible to protect the silyl ester from hydrolysis without 
diminishing fluoride incorporation by introducing bulky groups near the carbonyl function. To 
evaluate this idea, a geminal dimethyl group was introduced on the α-carbon of the ester, making 





Figure 3.8. Plausible mechanism of cleavage of silyl ester 
The α,α-dimethyl carboxylate linker was derived from 2,2-dimethyl-3-chloropropanoic 
acid. The chloride was replaced with N-Boc-2-amino ethanethiol, which further extended through 
an amide bond to introduce a terminal azide function, which can be clicked for loading onto the 
resin. Di-t-butyl chloro silane was then attached onto the carboxylic acid from the corresponding 
chlorosilane. 
 
Scheme 3.9. Preparation of resin supported silyl ester with α,α-dimethyl carboxylate linker 
F-18 water, straight from the cyclotron target and used without drying, was mixed with 
DMSO (1/5) and added to the resin. The desired prosthetic group 21 was released from the resin 
in 66% RCY at 50 °C within 10 minutes. Even though the F-18 incorporation was somewhat slower 
than with the resin without the geminal dimethyl substitution, 21 was generated in practical yield 
without NHS ester hydrolysis. The amount silyl alcohol was significantly reduced, enabling much 





Figure 3.9. HPLC trace of labeling of resin 34, with α,α-dimethyl carboxylate linkage. Blue: 
UV, Red: radio trace. Top: supernatant of reaction. Bottom: co-injected with cold standard. 
Retention time of 33 is 3.8 minutes.  
 
III. Conclusion 
The demand for simple, rapid and efficient radio labeling methods, kit-like radiosynthesis, 
is undeniable. Among those available positron-emitting nuclides, fluorine-18 has the most 
preferable characteristics, such as 1) long enough half-life, 2) lowest maximum energy and 3) 
pure decay mode. Although nucleophilic substitution at alkyl positions or on electron-deficient 
aromatic rings is widely used to label small molecules with fluorine-18, the rather harsh conditions 
required for these reactions are not optimal for the radiofluorination of large molecules, such as 
peptides or proteins. For years, extensive efforts have been placed on step-wise radiosynthesis 
of large molecules using prosthetic groups, but there is no widely applicable method and the 
requirement for time-consuming transformations and purifications make those methods far from 
practical. The highly fluorophilic elements, such as aluminum, boron and silicon, have received 
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increased attention in the F-18 radiochemistry field to develop novel and much more convenient 
radiofluorination methods that operate under much milder conditions. Our discovery of the novel 
precursor, silyl esters, has significantly extended the utility of silicon-based fluorine-18 labeling 
precursors through its ability to undergo [18F]fluoride incorporation under extremely mild 
conditions.   
To enable kit-like radiofluorination, we conceived of a resin-supported silyl ester as a 
precursor for F-18 labeling. With this resin, the F-18 labeled prosthetic group, [18F]fluoro-di(tert-
butyl)silyl benzoic acid N-hydroxysuccinimidyl ester, was released from the resin at room 
temperature using F-18 water straight from the cyclotron target. Furthermore, by loading a 
compound of interest on the resin first, treatment with F-18 water released labeled compound 
directly in a form that is likely ready to use for animals or patients. This represents a remarkable 
advance in radiochemistry because: 1) the labeling proceeds under aqueous conditions, which is 
ideal for biomolecules, 2) it does not require addition of excess base, which guarantees mild 
conditions, and 3) only labeled compound is released from resin, with unreacted substrate 
remaining on the resin, which ensures that purification is as simple as possible.  
While the reactive NHS ester survived under the labeling conditions, a small portion of the 
silyl ester was hydrolyzed, unexpectedly producing some amounts of silanol. By introducing steric 
hindrance around ester, the formation of this silanol byproduct was significantly reduced, while 
reactivity toward fluoride ion was maintained. Our current effort is to avoid silanol formation 
completely or to develop simple methods for removing the traces silanol from F-18 labeled 
product.   
IV. Methods 
Materials 
All reactions were carried out under a nitrogen atmosphere with dry solvents using anhydrous 
conditions unless otherwise stated. Solvents used in the reactions were dried in a solvent delivery 
system (neutral alumina column). Reagents were purchased from Aldrich and used without further 
purification, unless otherwise stated. Yields refer to chromatographically and spectroscopically 
(1H NMR) homogeneous materials, unless otherwise stated. Reactions were monitored by thin 
layer chromatography (TLC) carried out on Merck silica gel 60 F254 precoated plates (0.25 mm) 
using UV light as the visualizing agent and ceric ammonium molybdate and heat as developing 
agents. Flash column chromatography was performed on Silica P Flash silica gel (40-64 μM, 60 
Å) from SiliCycle. 1H NMR spectra were recorded at 23 oC on a Varian Unity-400, Varian Inova-
500 or Varian Unity-500 spectrometers and are reported in ppm using residual protium as the 
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internal standard (CHCl3, δ = 7.26, CD2HCN, δ = 1.94, center line, acetone-d6, δ = 2.05, center 
line). The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, 
dd = doublet of doublets, t = triplet, q = quartet, m = multiplet and b = broad. Proton-decoupled 
13C NMR spectra were recorded on a Varian Unity-500 (126 MHz) spectrometer and are reported 
in ppm using solvent as an internal standard (CDCl3, δ = 77.16, CD3CN, δ = 1.30, center line, 
acetone-d6, δ = 29.80, center line). High resolution mass spectra were obtained at the University 
of Illinois Mass Spectrometry Laboratory. No-carrier added [18F]fluoride was produced at 
Washington University Medical School by the 18O(p,n)18F reaction through proton irradiation of 
enriched (95%) [18O]H2O using a RDS111 cyclotron. Screw-cap test tubes used for drying fluoride 
and radiolabeling were purchased from Fisher Scientific (Pyrex No. 9825). Radiochemical 
purification utilized a reversed-phase semi-preparative HPLC column (HPLC: Thermo P2000, 
Column: Agilent Zorbax SB-C18, 5 µm, 9.4 X 250 mm, Product #: 880975-202, λ = 254 nm, 
ACN/H2O)). For quality control, the radiochemical purity was determined by analytical HPLC 
(HPLC: P4000, Column: Altima C18, 5 µm, 250 mm, Product #: 88056). C18 Sep-Pak cartridges 
were purchased from Waters Corporation (Milford, MA, USA). For the thin-layer chromatography 
(TLC) analyses, EM Science Silica Gel 60 F254 TLC plates were purchased from Fisher Scientific 
(Pittsburgh, PA, USA). Radio-TLC was accomplished using a Bioscan 200 imaging scanner 
(Bioscan, Inc., Washington, DC, USA). Radioactivity was counted with a Beckman Gamma 8000 
counter containing a NaI crystal (Beckman Instruments, Inc., Irvine, CA, USA). 
 
Radiochemical Syntheses 
General procedure of F-18 labeling with resin supported silyl ester 25.   
Dry method: F-18 water was added to the vial that contained n-Bu4N•HCO3 or K2CO3/K222, and 
the [18F]fluoride was dried azeotropically in CH3CN (1 mL) at 105 °C under stream of N2. The 
resulting dried activity was dissolve into reaction solvent and added to the resin 25. For the 





4-[18F]fluoro(di-tert-butyl)silyl benzoic acid N-hydroxysuccimidyl ester (21). 
entry Activity (mCi) Base (amount) solvent temp/time RCY (%) 
1 1.11 n-Bu4N•HCO3 (0.2 mg) DMSO rt/30 min 82 
2 2.54 K2CO3/K222 (0.1 mg/1.0 mg) DMSO rt/10 min 93 
3 3.03 n-Bu4N•HCO3 (0.2 mg) CH2Cl2 rt/45 min 17 
4a 1.07 n-Bu4N•HCO3 (0.2 mg) CH2Cl2 rt/30 min 42 
5 0.997 K2CO3/K222 (0.1 mg/1.0 mg) CH2Cl2 rt/10 min 18 
a2µl of TFA was added to reduce acidity. 
HPLC analysis  
















Entry 3  













Wet method: F-18 water was added to the vial that contained resin 25 swelled with solvent (F-
18 water:solvent = 1:5). For the analysis, small portion of supernatant was diluted with acetonitrile 
and analyzed by radio-TLC and HPLC.  
4-[18F]fluoro(di-tert-butyl)silyl benzoic acid N-hydroxysuccimidyl ester (25). 
entry Resin (mg) solvent Temp./time RCY Radiochemical 
purity 
1 2.3 CH3CN rt/25 min 82% 86% 
2 2.1 DMSO rt/30min 93% >98% 
3 2.7 DMF rt/25 min 91% 92% 
4 1.6 CH3CN 50 °C/10 min 75% 88% 
5 1.3 DMSO 50 °C/10 min 90% 93% 
6 1.0 DMSO 100 °C/5 min 98% 91% 
 
Radio-TLC of entry 2 (DMSO, rt, 30 min) 
TLC Eluting Conditions: 100% EtOAc 
DONG: 102312E.R01 









Region 1 (unreacted [18F]fluoride; 33 mm): 7.3% 
Region 2 ([18F]fluoroproduct; 75 mm): 92.7% 
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HPLC analysis  
Condition: 80% ACN, 20% H2O flow rate = 1.5 mL/ min, λ = 254 nm 
Entry 1 (CH3CN, rt, 25 min) 
Radio trace 
 
Entry 2 (DMSO, rt, 30 min) 
Radio trace 
 






Entry 4 (CH3CN, 50 ˚C, 10 min) 
Radio trace 
 
Entry 5 (DMSO, 50 ˚C, 10 min) 
Radio trace 
 







4-[18F]fluoro(di-tert-butyl)silyl benzoate conjugated estrogenic compound (29). To the 2.2 
mg of resin 28 was added 50 µl of DMSO. F-18 water straight from cyclotron (10 µl) was added 
to the suspension and the resulting mixture was shaken at 70 °C. To analyze the reaction, a small 
portion of supernatant was diluted with acetonitrile, and analyzed with radio-TLC and HPLC. 
 
Radio-TLC of labeling of 28 
TLC Eluting Conditions: 100% EtOAc 
DONG: 102512N.R01 









Region 1 (unreacted [18F]fluoride; 32 mm): 58.2% 
Region 2 ([18F]fluoroproduct; 55 mm): 41.8% 
HPLC analysis  








UV trace (co-injection with cold standard) 
 
 
4-[18F]fluoro(di-tert-butyl)silyl benzoate conjugated RGD-peptide (31).  
Direct label/release method. To the resin 31 was added 50 µl of solvent. F-18 water straight 
from cyclotron (10 µl) was added to the suspension and the resulting mixture was shaken at room 
temperature. To analyze the reaction, small portion of supernatant was diluted with acetonitrile, 
and analyzed with C-18 reverse phase TLC and HPLC. 
entry resin (mg) solvent temp./time RCY 
1 1.7 DMSO rt/30 min 51% 
2 1.8 CH3CN rt/10 min 32% 
 
Radio-TLC (DMSO, rt, 30 min) 
C-18 TLC Eluting Conditions: 20% MeOH/80% CH2Cl2 
Entry 2 (CH3CN, rt, 10 min) 
DONG: 102512D.R01 










Region 1 (unreacted [18F]fluoride; 33 mm): 67.8% 




HPLC analysis  
Condition: 30% ACN, 10% H2O to 90% ACN, 10% H2O (0.1%TFA) in 15min, λ = 254 nm 

















Label/release-conjugation method. To the resin 25 (3.5 mg) was added 150 µl of DMSO. F-18 
water straight from cyclotron (30 µl, 1.27 mCi) was added to the suspension and the resulting 
mixture was shaken at room temperature for 20 minutes. The half of the reaction mixture (0.38 
mCi) was placed onto Alumina Sep-pak®. 0.28 mCi of activity was eluted with 200 µl of DMF, and 
0.10 mCi was eluted with another 200 µl of DMF. First fraction (0.28 mCi) was separated into two 
fractions and each was used the following conjugation reaction. 0.3 mg of RGD peptide 32 was 
dissolved into 50 μl of solvent and the activity was added to the mixture and shaken at room 
temperature. The conjugation was monitored by HPLC. 
entry RDG peptide activity of 21 solvent time yield 
1 0.3 mg 0.14 mCi MeOH 50 min 12% 





Radio TLC or label/release step (21) 
Elution condition: 100% EtOAc 
DONG: 1213125.R01 









Region 1 (unreacted [18F]fluoride; 33 mm): 54.5% 
Region 2 ([18F]fluoroproduct; 56 mm): 45.5% 
HPLC analysis of label/release step (21) 
Condition: 80% ACN, 20% H2O flow rate = 1.5 mL/ min, λ = 254 nm 
Radio trace 
 
HPLC analysis of conjugation step (31) 
Condition: 30% ACN, 10% H2O to 90% ACN, 10% H2O (0.1%TFA) in 15min, λ = 254 nm 








Area ratio between 7.8 min peak ([18F]labeled RGD 31) and 15.3 min peak (21) is 12:88 
 
UV trace (co-injected with cold standard) 
 










Formation of silanol (33) from resin 25. To the resin 25 (2.2 mg) was added 50 µl of DMSO 
and 10 µl of water. The mixture was shaken at room temperature. 20 µl of supernatant was taken 
at 0 min, 6.5 min, 15 min and 30 min, and each was diluted with 0.5 mL of CH3CN. 30 µl of the 
sample was injected onto HPLC. 
HPLC analysis of formation of silanol 33. 
Condition: 80% ACN, 20% H2O, Flow rate = 2 mL/min, λ = 254 nm 
 
Peaks at 2.9 min, 10.4 min, 18.2 min and 33.2 min are silanol 33 formed at 0 min, 6.5 min, 15 min 
and 30 min, respectively.  
F-18 labeling with resin supported silyl ester with α,α-dimethyl carboxylate linker (34).  To 
the resin 34 was added 50 µl of solvent. After 10 µl of F-18 water straight from cyclotron was 
added, the mixture was shaken. For analysis of the labeling, small portion of the supernatant was 
diluted with CH3CN, and analyzed with radio-TLC and HPLC.  
entry resin solvent temp./time RCY 
1 0.7 mg DMSO rt/10 min 18% (21%@30min) 
2 1.5 mg CH3CN rt/10 min 18% 
3 1.1 mg DMSO 50 °C/10 min 66% 
4 1.1 mg CH3CN 50 °C/10 min 28% 
5 1.0 mg DMSO 75 °C/10 min 58% 
6 1.3 mg DMSO 100 °C/10 min 54% 





Radio-TLC and HPLC 
TLC Eluting Conditions: 100% EtOAc 
HPLC Condition: 80% ACN, 20% H2O flow rate = 1.5 mL/ min, λ = 254 nm 
 
Entry 1 (DMSO, rt) 
TLC 
DONG: 402141.R01 










Region 1 (unreacted [18F]fluoride; 33 mm): 82.2% 
Region 2 ([18F]fluoroproduct; 57 mm): 17.8% 
HPLC (blue: UV, red: radio) 
 
Entry 2 (ACN, rt) 
TLC 
DONG: 402143.R01 












Region 1 (unreacted [18F]fluoride; 33 mm): 81.7% 
Region 2 ([18F]fluoroproduct; 65 mm): 18.3% 
HPLC (blue: UV, red: radio) 
 
Entry 2 (DMSO, 50 °C) 
TLC 
DONG: 402144.R01 








Region 1 (unreacted [18F]fluoride; 33 mm): 33.2% 
Region 2 (unknown labeled product; 53 mm): 4.6% 




Entry 4 (ACN, 50 °C) 
DONG: 402145.R01 











Region 1 (unreacted [18F]fluoride; 33 mm): 72.4% 
Region 2 ([18F]fluoroproduct; 58 mm): 27.6% 
Entry 5 (DMSO, 75 °C) 
TLC 
DONG: 402149.R01 








Region 1 (unreacted [18F]fluoride; 33 mm): 41.8% 
Region 2 ([18F]fluoroproduct; 58 mm): 58.2% 





Entry 6 (DMSO, 100 °C) 
TLC 
DONG: 402146.R01 








Region 1 (unreacted [18F]fluoride; 33 mm): 30.5% 
Region 2 (unknown labeled product; 46 mm); 14.9 % 
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